_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
503729615,7/16/2014 22:29:09,,1324512941,7/16/2014 22:28:49,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,BREAST CANCER is location of BREAST EPITHELIAL STEM CELLS,0,87,,27,100,is location of,0.949425326555083,902071-FS1-9,BREAST EPITHELIAL STEM CELLS are thought to be the primary targets in the aetiology of BREAST CANCER,BREAST EPITHELIAL STEM CELLS,BREAST CANCER,RO-disease_has_primary_anatomic_site
503729615,7/16/2014 22:29:49,,1324513241,7/16/2014 22:29:41,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,BREAST EPITHELIAL STEM CELLS is location of BREAST CANCER,0,87,,27,100,is location of,0.949425326555083,902071-FS1-9,BREAST EPITHELIAL STEM CELLS are thought to be the primary targets in the aetiology of BREAST CANCER,BREAST EPITHELIAL STEM CELLS,BREAST CANCER,RO-disease_has_primary_anatomic_site
503729615,7/17/2014 00:09:01,,1324554501,7/17/2014 00:08:37,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,BREAST EPITHELIAL STEM CELLS is location of BREAST CANCER,0,87,,27,100,is location of,0.949425326555083,902071-FS1-9,BREAST EPITHELIAL STEM CELLS are thought to be the primary targets in the aetiology of BREAST CANCER,BREAST EPITHELIAL STEM CELLS,BREAST CANCER,RO-disease_has_primary_anatomic_site
503729615,7/17/2014 00:47:36,,1324582155,7/17/2014 00:46:51,instagc,0.4167,19745059,CAN,ON,Saint Catharines,216.121.166.67,BREAST CANCER is location of BREAST EPITHELIAL STEM CELLS,0,87,,27,100,is location of,0.949425326555083,902071-FS1-9,BREAST EPITHELIAL STEM CELLS are thought to be the primary targets in the aetiology of BREAST CANCER,BREAST EPITHELIAL STEM CELLS,BREAST CANCER,RO-disease_has_primary_anatomic_site
503729615,7/17/2014 02:18:24,,1324670393,7/17/2014 02:18:09,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,BREAST EPITHELIAL STEM CELLS is location of BREAST CANCER,0,87,,27,100,is location of,0.949425326555083,902071-FS1-9,BREAST EPITHELIAL STEM CELLS are thought to be the primary targets in the aetiology of BREAST CANCER,BREAST EPITHELIAL STEM CELLS,BREAST CANCER,RO-disease_has_primary_anatomic_site
503729615,7/17/2014 06:04:58,,1324878966,7/17/2014 06:04:37,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,BREAST EPITHELIAL STEM CELLS is location of BREAST CANCER,0,87,,27,100,is location of,0.949425326555083,902071-FS1-9,BREAST EPITHELIAL STEM CELLS are thought to be the primary targets in the aetiology of BREAST CANCER,BREAST EPITHELIAL STEM CELLS,BREAST CANCER,RO-disease_has_primary_anatomic_site
503729615,7/17/2014 06:12:53,,1324885715,7/17/2014 06:12:37,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,BREAST EPITHELIAL STEM CELLS is location of BREAST CANCER,0,87,,27,100,is location of,0.949425326555083,902071-FS1-9,BREAST EPITHELIAL STEM CELLS are thought to be the primary targets in the aetiology of BREAST CANCER,BREAST EPITHELIAL STEM CELLS,BREAST CANCER,RO-disease_has_primary_anatomic_site
503729616,7/16/2014 22:23:21,,1324510481,7/16/2014 22:22:40,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.983078304622849,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 01:32:22,,1324624961,7/17/2014 01:32:17,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.983078304622849,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 03:08:26,,1324721086,7/17/2014 03:08:06,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.983078304622849,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 04:55:38,,1324820091,7/17/2014 04:55:06,prodege,0.7105,27934334,GBR,"","",86.130.153.15,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.983078304622849,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 06:05:06,,1324879056,7/17/2014 06:04:31,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.983078304622849,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 07:45:06,,1324979737,7/17/2014 07:44:55,instagc,0.698,18960682,GBR,"","",86.29.147.112,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.983078304622849,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729616,7/17/2014 10:37:22,,1325144097,7/17/2014 10:37:08,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,METHOTREXATE treats LEUKEMIA,28,60,,35,72,treats,0.983078304622849,908155-FS1-2,We report two patients with LEUKEMIA treated with high dose METHOTREXATE,LEUKEMIA,METHOTREXATE,RO-may_treat
503729617,7/16/2014 22:36:21,,1324516067,7/16/2014 22:36:02,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,CISAPRIDE causes FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/16/2014 22:45:06,,1324519368,7/16/2014 22:44:50,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,CISAPRIDE causes FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/16/2014 23:11:23,,1324529206,7/16/2014 23:10:45,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS causes CISAPRIDE,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/16/2014 23:43:00,,1324543096,7/16/2014 23:42:08,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,CISAPRIDE causes FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/17/2014 00:49:09,,1324583526,7/17/2014 00:49:05,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS causes CISAPRIDE,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/17/2014 01:24:51,,1324617124,7/17/2014 01:24:17,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS causes CISAPRIDE,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729617,7/17/2014 06:03:06,,1324877514,7/17/2014 06:02:27,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,CISAPRIDE causes FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,30,17,,81,26,causes,0.560112033611204,908361-FS1-4,"The influence of CISAPRIDE on FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS was studied in a double blind cross over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro oesophageal reflux and 12 with additional macroscopic oesophagitis.",FOOD STIMULATED GASTRO OESOPHAGEAL REFLUX MECHANISMS,CISAPRIDE,RO-may_treat
503729618,7/16/2014 22:37:24,,1324516560,7/16/2014 22:36:56,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,no_relation,146,201,,173,217,causes,0.771516749810459,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/16/2014 23:25:29,,1324535709,7/16/2014 23:25:02,instagc,0.7639,13763729,USA,"","",75.182.89.225,NEUROPATHIC PAIN causes PAIN CAUSED BY SOMATOSENSORY,146,201,,173,217,causes,0.771516749810459,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/16/2014 23:43:33,,1324543271,7/16/2014 23:43:15,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,NEUROPATHIC PAIN causes PAIN CAUSED BY SOMATOSENSORY,146,201,,173,217,causes,0.771516749810459,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/17/2014 00:33:39,,1324568919,7/17/2014 00:32:55,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,PAIN CAUSED BY SOMATOSENSORY causes NEUROPATHIC PAIN,146,201,,173,217,causes,0.771516749810459,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/17/2014 01:12:50,,1324605877,7/17/2014 01:11:49,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,PAIN CAUSED BY SOMATOSENSORY causes NEUROPATHIC PAIN,146,201,,173,217,causes,0.771516749810459,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/17/2014 01:39:41,,1324632556,7/17/2014 01:38:53,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,no_relation,146,201,,173,217,causes,0.771516749810459,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729618,7/17/2014 10:32:57,,1325140414,7/17/2014 10:32:50,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,NEUROPATHIC PAIN causes PAIN CAUSED BY SOMATOSENSORY,146,201,,173,217,causes,0.771516749810459,904937-FS1-4,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) PAIN CAUSED BY SOMATOSENSORY system disease or damage (NEUROPATHIC PAIN and (3) pain without a known somatic background.",PAIN CAUSED BY SOMATOSENSORY,NEUROPATHIC PAIN,RO-has_definitional_manifestation
503729619,7/16/2014 22:28:26,,1324512720,7/16/2014 22:28:00,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,139,43,,159,69,causes,0.702246883176783,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/16/2014 23:09:47,,1324528606,7/16/2014 23:09:10,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,INSULIN DEPENDENT DIABETES causes DIABETIC KETOACIDOSIS,139,43,,159,69,causes,0.702246883176783,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/17/2014 00:16:40,,1324557442,7/17/2014 00:16:19,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,139,43,,159,69,causes,0.702246883176783,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/17/2014 00:48:57,,1324583326,7/17/2014 00:48:51,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,INSULIN DEPENDENT DIABETES causes DIABETIC KETOACIDOSIS,139,43,,159,69,causes,0.702246883176783,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/17/2014 04:44:33,,1324810425,7/17/2014 04:44:16,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,INSULIN DEPENDENT DIABETES causes DIABETIC KETOACIDOSIS,139,43,,159,69,causes,0.702246883176783,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/17/2014 04:57:06,,1324821413,7/17/2014 04:56:26,prodege,0.7105,27934334,GBR,"","",86.130.153.15,INSULIN DEPENDENT DIABETES causes DIABETIC KETOACIDOSIS,139,43,,159,69,causes,0.702246883176783,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/17/2014 06:39:30,,1324909279,7/17/2014 06:39:06,instagc,0.5978,18634892,USA,"","",68.102.93.185,INSULIN DEPENDENT DIABETES causes DIABETIC KETOACIDOSIS,139,43,,159,69,causes,0.702246883176783,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729620,7/16/2014 22:25:19,,1324511175,7/16/2014 22:25:09,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590-FS1-2,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
503729620,7/16/2014 22:26:04,,1324511531,7/16/2014 22:25:33,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590-FS1-2,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
503729620,7/16/2014 22:56:27,,1324524025,7/16/2014 22:56:02,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590-FS1-2,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
503729620,7/16/2014 23:55:28,,1324547781,7/16/2014 23:55:18,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590-FS1-2,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
503729620,7/17/2014 00:10:39,,1324555161,7/17/2014 00:10:23,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590-FS1-2,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
503729620,7/17/2014 01:39:41,,1324632555,7/17/2014 01:38:53,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590-FS1-2,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
503729620,7/17/2014 04:45:25,,1324811273,7/17/2014 04:45:14,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590-FS1-2,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
503729621,7/16/2014 22:34:20,,1324515013,7/16/2014 22:34:02,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,ATOPY causes HAY FEVER,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/16/2014 22:57:47,,1324524501,7/16/2014 22:57:01,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,ATOPY causes HAY FEVER,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/16/2014 23:00:24,,1324525353,7/16/2014 23:00:02,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/16/2014 23:09:24,,1324528468,7/16/2014 23:08:39,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/16/2014 23:16:53,,1324531353,7/16/2014 23:15:59,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,ATOPY causes HAY FEVER,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/16/2014 23:26:15,,1324536049,7/16/2014 23:25:51,instagc,0.7639,13763729,USA,"","",75.182.89.225,no_relation,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729621,7/17/2014 00:19:08,,1324558600,7/17/2014 00:18:50,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,99,154,,107,159,causes,0.488677777425221,900242-FS1-4,Malignancies were observed less frequently in the closest relatives of the patients suffering from HAY FEVER with the most proved hereditary liability of ATOPY than in the relatives of control groups.,HAY FEVER,ATOPY,RO-cause_of
503729622,7/16/2014 23:25:18,,1324535662,7/16/2014 23:24:56,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,ENDEMIC GOITER causes SELENIUM (SE) DEFICIENCY,94,0,,107,24,causes,0.943456353049726,900255-FS1-4,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729622,7/17/2014 08:47:24,,1325044085,7/17/2014 08:47:05,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,SELENIUM (SE) DEFICIENCY causes ENDEMIC GOITER,94,0,,107,24,causes,0.943456353049726,900255-FS1-4,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729622,7/17/2014 10:33:44,,1325141151,7/17/2014 10:33:35,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,SELENIUM (SE) DEFICIENCY causes ENDEMIC GOITER,94,0,,107,24,causes,0.943456353049726,900255-FS1-4,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729622,7/17/2014 10:35:05,,1325142279,7/17/2014 10:34:52,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,SELENIUM (SE) DEFICIENCY causes ENDEMIC GOITER,94,0,,107,24,causes,0.943456353049726,900255-FS1-4,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729622,7/17/2014 10:36:09,,1325143179,7/17/2014 10:35:46,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,ENDEMIC GOITER causes SELENIUM (SE) DEFICIENCY,94,0,,107,24,causes,0.943456353049726,900255-FS1-4,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729622,7/17/2014 10:59:28,,1325160778,7/17/2014 10:58:54,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,94,0,,107,24,causes,0.943456353049726,900255-FS1-4,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729622,7/17/2014 11:11:07,,1325169680,7/17/2014 11:10:44,prodege,0.5714,15439740,AUS,02,Jannali,27.96.208.89,SELENIUM (SE) DEFICIENCY causes ENDEMIC GOITER,94,0,,107,24,causes,0.943456353049726,900255-FS1-4,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729623,7/16/2014 22:28:59,,1324512897,7/16/2014 22:28:44,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,PAIN causes CLUSTER HEADACHE,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/16/2014 23:11:23,,1324529207,7/16/2014 23:10:45,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,CLUSTER HEADACHE causes PAIN,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/16/2014 23:17:25,,1324531613,7/16/2014 23:16:55,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,CLUSTER HEADACHE causes PAIN,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/16/2014 23:44:20,,1324543536,7/16/2014 23:43:46,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,CLUSTER HEADACHE causes PAIN,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/17/2014 00:16:40,,1324557437,7/17/2014 00:16:19,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/17/2014 01:11:23,,1324604481,7/17/2014 01:11:05,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,CLUSTER HEADACHE causes PAIN,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729623,7/17/2014 01:32:39,,1324625262,7/17/2014 01:32:33,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,CLUSTER HEADACHE causes PAIN,70,53,,73,69,causes,0.923380516876639,904783-FS1-4,"Although the pain in both disorders is excruciating, CLUSTER HEADACHE PAIN is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",PAIN,CLUSTER HEADACHE,RO-has_definitional_manifestation
503729624,7/16/2014 22:46:05,,1324519801,7/16/2014 22:45:50,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,DIABETES treats ISLET CELL NEOGENESIS,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/16/2014 23:09:56,,1324528680,7/16/2014 23:09:25,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,ISLET CELL NEOGENESIS treats DIABETES,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/16/2014 23:37:25,,1324540838,7/16/2014 23:36:53,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,ISLET CELL NEOGENESIS treats DIABETES,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/16/2014 23:43:31,,1324543260,7/16/2014 23:43:02,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,ISLET CELL NEOGENESIS treats DIABETES,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/17/2014 00:48:57,,1324583355,7/17/2014 00:48:51,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,DIABETES treats ISLET CELL NEOGENESIS,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/17/2014 01:13:46,,1324606707,7/17/2014 01:13:21,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,ISLET CELL NEOGENESIS treats DIABETES,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729624,7/17/2014 01:26:55,,1324619122,7/17/2014 01:26:21,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,ISLET CELL NEOGENESIS treats DIABETES,91,79,,111,87,treats,0.99654575824488,902134-FS1-2,"If islet cell tolerance could be re induced, a major clinical hurdle to curing DIABETES by ISLET CELL NEOGENESIS may be overcome.",ISLET CELL NEOGENESIS,DIABETES,RO-disease_has_primary_anatomic_site
503729625,7/16/2014 22:28:41,,1324512798,7/16/2014 22:28:32,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,EPILEPTIC SEIZURES causes SEIZURES,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/16/2014 23:55:16,,1324547693,7/16/2014 23:55:00,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,EPILEPTIC SEIZURES causes SEIZURES,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/17/2014 03:42:18,,1324753711,7/17/2014 03:41:45,instagc,0.7319,20183814,USA,"","",166.182.81.199,EPILEPTIC SEIZURES causes SEIZURES,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/17/2014 04:57:30,,1324821840,7/17/2014 04:57:07,prodege,0.7105,27934334,GBR,"","",86.130.153.15,no_relation,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/17/2014 07:31:29,,1324964711,7/17/2014 07:30:39,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,EPILEPTIC SEIZURES causes SEIZURES,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/17/2014 10:03:04,,1325115955,7/17/2014 10:02:38,prodege,0.7163,25949006,GBR,"","",62.249.242.67,no_relation,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/17/2014 10:35:59,,1325143096,7/17/2014 10:35:41,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,SEIZURES causes EPILEPTIC SEIZURES,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729626,7/16/2014 23:25:50,,1324535872,7/16/2014 23:25:29,instagc,0.7639,13763729,USA,"","",75.182.89.225,PRINZMETAL VARIANT ANGINA diagnosed by ERGOMETRINE,44,0,,68,11,diagnosed by,0.970142500145332,906617-FS1-13,"ERGOMETRINE is currently used as a test for PRINZMETAL VARIANT ANGINA causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",PRINZMETAL VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
503729626,7/17/2014 01:11:23,,1324604478,7/17/2014 01:11:05,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,PRINZMETAL VARIANT ANGINA diagnosed by ERGOMETRINE,44,0,,68,11,diagnosed by,0.970142500145332,906617-FS1-13,"ERGOMETRINE is currently used as a test for PRINZMETAL VARIANT ANGINA causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",PRINZMETAL VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
503729626,7/17/2014 06:05:44,,1324879611,7/17/2014 06:05:28,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,PRINZMETAL VARIANT ANGINA diagnosed by ERGOMETRINE,44,0,,68,11,diagnosed by,0.970142500145332,906617-FS1-13,"ERGOMETRINE is currently used as a test for PRINZMETAL VARIANT ANGINA causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",PRINZMETAL VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
503729626,7/17/2014 07:32:05,,1324965370,7/17/2014 07:31:31,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,PRINZMETAL VARIANT ANGINA diagnosed by ERGOMETRINE,44,0,,68,11,diagnosed by,0.970142500145332,906617-FS1-13,"ERGOMETRINE is currently used as a test for PRINZMETAL VARIANT ANGINA causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",PRINZMETAL VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
503729626,7/17/2014 07:44:55,,1324979578,7/17/2014 07:44:41,instagc,0.698,18960682,GBR,"","",86.29.147.112,PRINZMETAL VARIANT ANGINA diagnosed by ERGOMETRINE,44,0,,68,11,diagnosed by,0.970142500145332,906617-FS1-13,"ERGOMETRINE is currently used as a test for PRINZMETAL VARIANT ANGINA causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",PRINZMETAL VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
503729626,7/17/2014 08:48:30,,1325045135,7/17/2014 08:48:11,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,PRINZMETAL VARIANT ANGINA diagnosed by ERGOMETRINE,44,0,,68,11,diagnosed by,0.970142500145332,906617-FS1-13,"ERGOMETRINE is currently used as a test for PRINZMETAL VARIANT ANGINA causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",PRINZMETAL VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
503729626,7/17/2014 10:32:37,,1325140136,7/17/2014 10:32:28,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,44,0,,68,11,diagnosed by,0.970142500145332,906617-FS1-13,"ERGOMETRINE is currently used as a test for PRINZMETAL VARIANT ANGINA causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",PRINZMETAL VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
503729627,7/16/2014 22:29:09,,1324512940,7/16/2014 22:28:52,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,78,157,,99,166,diagnosed by,0.995893206467704,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/16/2014 22:31:26,,1324513905,7/16/2014 22:30:48,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,MALIGNANT HYPERTHERMIA diagnosed by HALOTHANE,78,157,,99,166,diagnosed by,0.995893206467704,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/17/2014 00:49:09,,1324583525,7/17/2014 00:49:05,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,HALOTHANE diagnosed by MALIGNANT HYPERTHERMIA,78,157,,99,166,diagnosed by,0.995893206467704,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/17/2014 02:37:32,,1324690030,7/17/2014 02:36:49,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,78,157,,99,166,diagnosed by,0.995893206467704,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/17/2014 03:09:52,,1324722431,7/17/2014 03:09:29,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,MALIGNANT HYPERTHERMIA diagnosed by HALOTHANE,78,157,,99,166,diagnosed by,0.995893206467704,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/17/2014 07:05:26,,1324934915,7/17/2014 07:05:16,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,78,157,,99,166,diagnosed by,0.995893206467704,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729627,7/17/2014 07:44:28,,1324979040,7/17/2014 07:44:11,instagc,0.698,18960682,GBR,"","",86.29.147.112,HALOTHANE diagnosed by MALIGNANT HYPERTHERMIA,78,157,,99,166,diagnosed by,0.995893206467704,906943-FS1-13,In view of the wide spectrum of drug sensitivity characterizing subjects with MALIGNANT HYPERTHERMIA it is suggested that exposure to A23187 be added to the HALOTHANE and caffeine tests currently used to detect this disease.,MALIGNANT HYPERTHERMIA,HALOTHANE,RO-may_diagnose
503729628,7/16/2014 22:29:06,,1324512931,7/16/2014 22:28:43,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.993127066322841,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/16/2014 23:08:02,,1324528022,7/16/2014 23:07:37,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.993127066322841,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/16/2014 23:14:49,,1324530533,7/16/2014 23:14:25,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.993127066322841,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/16/2014 23:33:20,,1324538990,7/16/2014 23:33:03,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.993127066322841,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/16/2014 23:43:44,,1324543348,7/16/2014 23:43:33,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,SCHIZOPHRENIA treats LONG ACTING RISPERIDONE,96,13,,108,36,treats,0.993127066322841,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/17/2014 06:04:30,,1324878544,7/17/2014 06:03:48,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.993127066322841,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729628,7/17/2014 09:32:15,,1325086517,7/17/2014 09:31:47,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,LONG ACTING RISPERIDONE treats SCHIZOPHRENIA,96,13,,108,36,treats,0.993127066322841,908025-FS1-2,CONCLUSIONS: LONG ACTING RISPERIDONE is effective and generally well tolerated in patients with SCHIZOPHRENIA including those patients with stable symptoms.,SCHIZOPHRENIA,LONG ACTING RISPERIDONE,RO-may_treat
503729629,7/16/2014 22:25:32,,1324511258,7/16/2014 22:24:58,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,BLOOD PRESSURE ELEVATION causes HYPERTENSION,137,208,,160,220,causes,0.729324957489473,904540-FS1-4,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729629,7/16/2014 22:28:36,,1324512776,7/16/2014 22:28:23,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,HYPERTENSION causes BLOOD PRESSURE ELEVATION,137,208,,160,220,causes,0.729324957489473,904540-FS1-4,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729629,7/16/2014 22:32:35,,1324514283,7/16/2014 22:32:02,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,BLOOD PRESSURE ELEVATION causes HYPERTENSION,137,208,,160,220,causes,0.729324957489473,904540-FS1-4,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729629,7/16/2014 22:49:48,,1324521177,7/16/2014 22:49:10,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,HYPERTENSION causes BLOOD PRESSURE ELEVATION,137,208,,160,220,causes,0.729324957489473,904540-FS1-4,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729629,7/16/2014 23:36:51,,1324540631,7/16/2014 23:36:25,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,BLOOD PRESSURE ELEVATION causes HYPERTENSION,137,208,,160,220,causes,0.729324957489473,904540-FS1-4,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729629,7/17/2014 01:32:09,,1324624852,7/17/2014 01:31:59,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,HYPERTENSION causes BLOOD PRESSURE ELEVATION,137,208,,160,220,causes,0.729324957489473,904540-FS1-4,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729629,7/17/2014 04:57:06,,1324821415,7/17/2014 04:56:26,prodege,0.7105,27934334,GBR,"","",86.130.153.15,no_relation,137,208,,160,220,causes,0.729324957489473,904540-FS1-4,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729630,7/16/2014 22:29:09,,1324512964,7/16/2014 22:28:52,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,MALIGNANT MELANOMA causes MELANOMA PAN,158,60,,169,78,causes,0.314485451016576,906345-FS1-4,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729630,7/16/2014 23:36:23,,1324540394,7/16/2014 23:35:44,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,no_relation,158,60,,169,78,causes,0.314485451016576,906345-FS1-4,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729630,7/17/2014 01:38:50,,1324631736,7/17/2014 01:38:07,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,MELANOMA PAN causes MALIGNANT MELANOMA,158,60,,169,78,causes,0.314485451016576,906345-FS1-4,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729630,7/17/2014 02:34:19,,1324686595,7/17/2014 02:33:34,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,158,60,,169,78,causes,0.314485451016576,906345-FS1-4,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729630,7/17/2014 06:04:36,,1324878619,7/17/2014 06:04:16,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,no_relation,158,60,,169,78,causes,0.314485451016576,906345-FS1-4,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729630,7/17/2014 07:47:27,,1324982282,7/17/2014 07:46:44,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,no_relation,158,60,,169,78,causes,0.314485451016576,906345-FS1-4,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729630,7/17/2014 09:29:31,,1325083085,7/17/2014 09:28:15,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,MELANOMA PAN causes MALIGNANT MELANOMA,158,60,,169,78,causes,0.314485451016576,906345-FS1-4,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729631,7/17/2014 03:08:02,,1324720709,7/17/2014 03:07:38,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 07:32:05,,1324965372,7/17/2014 07:31:31,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 10:33:09,,1325140595,7/17/2014 10:32:59,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 10:34:31,,1325141784,7/17/2014 10:34:10,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 10:36:28,,1325143452,7/17/2014 10:36:10,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 10:59:28,,1325160776,7/17/2014 10:58:54,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729631,7/17/2014 11:11:37,,1325170194,7/17/2014 11:11:10,prodege,0.5714,15439740,AUS,02,Jannali,27.96.208.89,GLUCOSE IV treats SEVERE HYPOGLYCAEMIA (SH),95,136,,119,146,treats,0.913811548620257,908138-FS1-2,The objectives of the present analyses were to assess the association between HbA1c levels and SEVERE HYPOGLYCAEMIA (SH) treatment with GLUCOSE IV.,SEVERE HYPOGLYCAEMIA (SH),GLUCOSE IV,RO-may_treat
503729632,7/16/2014 23:01:00,,1324525498,7/16/2014 23:00:50,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 02:34:19,,1324686575,7/17/2014 02:33:34,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,LOW DOSE HEPARIN PROPHYLA causes MBOLISM AFTER MA,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 06:05:06,,1324879055,7/17/2014 06:04:31,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,no_relation,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 07:47:27,,1324982283,7/17/2014 07:46:44,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,no_relation,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 07:58:20,,1324993571,7/17/2014 07:57:35,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 08:47:24,,1325044079,7/17/2014 08:47:05,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,MBOLISM AFTER MA causes LOW DOSE HEPARIN PROPHYLA,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729632,7/17/2014 10:32:27,,1325140008,7/17/2014 10:32:18,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,162,113,,177,138,causes,0.50709255283711,907131-FS1-4,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729633,7/16/2014 22:24:36,,1324510907,7/16/2014 22:24:21,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,167,206,,193,216,causes,0.957826285221151,906561-FS1-4,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with VASOSPASTIC ANGINA PECTORIS induced by ERGONOVINE",VASOSPASTIC ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729633,7/16/2014 23:35:42,,1324540037,7/16/2014 23:35:10,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,ERGONOVINE causes VASOSPASTIC ANGINA PECTORIS,167,206,,193,216,causes,0.957826285221151,906561-FS1-4,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with VASOSPASTIC ANGINA PECTORIS induced by ERGONOVINE",VASOSPASTIC ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729633,7/17/2014 03:08:26,,1324721085,7/17/2014 03:08:06,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,VASOSPASTIC ANGINA PECTORIS causes ERGONOVINE,167,206,,193,216,causes,0.957826285221151,906561-FS1-4,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with VASOSPASTIC ANGINA PECTORIS induced by ERGONOVINE",VASOSPASTIC ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729633,7/17/2014 03:40:40,,1324752237,7/17/2014 03:39:55,instagc,0.7319,20183814,USA,"","",166.182.81.199,ERGONOVINE causes VASOSPASTIC ANGINA PECTORIS,167,206,,193,216,causes,0.957826285221151,906561-FS1-4,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with VASOSPASTIC ANGINA PECTORIS induced by ERGONOVINE",VASOSPASTIC ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729633,7/17/2014 06:05:44,,1324879612,7/17/2014 06:05:28,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,ERGONOVINE causes VASOSPASTIC ANGINA PECTORIS,167,206,,193,216,causes,0.957826285221151,906561-FS1-4,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with VASOSPASTIC ANGINA PECTORIS induced by ERGONOVINE",VASOSPASTIC ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729633,7/17/2014 10:37:26,,1325144165,7/17/2014 10:37:00,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,ERGONOVINE causes VASOSPASTIC ANGINA PECTORIS,167,206,,193,216,causes,0.957826285221151,906561-FS1-4,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with VASOSPASTIC ANGINA PECTORIS induced by ERGONOVINE",VASOSPASTIC ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729633,7/17/2014 10:37:41,,1325144292,7/17/2014 10:37:22,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,ERGONOVINE causes VASOSPASTIC ANGINA PECTORIS,167,206,,193,216,causes,0.957826285221151,906561-FS1-4,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with VASOSPASTIC ANGINA PECTORIS induced by ERGONOVINE",VASOSPASTIC ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729634,7/16/2014 22:29:25,,1324513046,7/16/2014 22:29:16,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,FLUORIDES treats CARIES,30,40,,35,49,treats,0.953462589245592,907302-FS1-2,In the past the inhibition of CARIES by FLUORIDES was ascribed to the reduced solubility of enamel due to the incorporation of F  into the enamel mineral.,CARIES,FLUORIDES,RO-may_prevent
503729634,7/16/2014 23:43:00,,1324543097,7/16/2014 23:42:08,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,FLUORIDES treats CARIES,30,40,,35,49,treats,0.953462589245592,907302-FS1-2,In the past the inhibition of CARIES by FLUORIDES was ascribed to the reduced solubility of enamel due to the incorporation of F  into the enamel mineral.,CARIES,FLUORIDES,RO-may_prevent
503729634,7/17/2014 03:41:29,,1324752974,7/17/2014 03:41:06,instagc,0.7319,20183814,USA,"","",166.182.81.199,FLUORIDES treats CARIES,30,40,,35,49,treats,0.953462589245592,907302-FS1-2,In the past the inhibition of CARIES by FLUORIDES was ascribed to the reduced solubility of enamel due to the incorporation of F  into the enamel mineral.,CARIES,FLUORIDES,RO-may_prevent
503729634,7/17/2014 04:57:56,,1324822327,7/17/2014 04:57:32,prodege,0.7105,27934334,GBR,"","",86.130.153.15,FLUORIDES treats CARIES,30,40,,35,49,treats,0.953462589245592,907302-FS1-2,In the past the inhibition of CARIES by FLUORIDES was ascribed to the reduced solubility of enamel due to the incorporation of F  into the enamel mineral.,CARIES,FLUORIDES,RO-may_prevent
503729634,7/17/2014 06:39:05,,1324908911,7/17/2014 06:38:34,instagc,0.5978,18634892,USA,"","",68.102.93.185,no_relation,30,40,,35,49,treats,0.953462589245592,907302-FS1-2,In the past the inhibition of CARIES by FLUORIDES was ascribed to the reduced solubility of enamel due to the incorporation of F  into the enamel mineral.,CARIES,FLUORIDES,RO-may_prevent
503729634,7/17/2014 07:30:03,,1324963120,7/17/2014 07:29:46,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,FLUORIDES treats CARIES,30,40,,35,49,treats,0.953462589245592,907302-FS1-2,In the past the inhibition of CARIES by FLUORIDES was ascribed to the reduced solubility of enamel due to the incorporation of F  into the enamel mineral.,CARIES,FLUORIDES,RO-may_prevent
503729634,7/17/2014 10:03:33,,1325116453,7/17/2014 10:03:05,prodege,0.7163,25949006,GBR,"","",62.249.242.67,FLUORIDES treats CARIES,30,40,,35,49,treats,0.953462589245592,907302-FS1-2,In the past the inhibition of CARIES by FLUORIDES was ascribed to the reduced solubility of enamel due to the incorporation of F  into the enamel mineral.,CARIES,FLUORIDES,RO-may_prevent
503729635,7/16/2014 22:28:47,,1324512838,7/16/2014 22:28:28,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,89,89,,117,109,causes,0.964763821237732,900138-FS1-4,"However, the children who were exposed to a dog at home during early childhood developed DOG HYPERSENSITIVITY SYMPTOMS significantly earlier and had DOG HYPERSENSITIVITY slightly more often than the subjects with a later exposure or no exposure to dog.",DOG HYPERSENSITIVITY SYMPTOMS,DOG HYPERSENSITIVITY,RO-cause_of
503729635,7/16/2014 23:12:51,,1324529806,7/16/2014 23:12:09,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,89,89,,117,109,causes,0.964763821237732,900138-FS1-4,"However, the children who were exposed to a dog at home during early childhood developed DOG HYPERSENSITIVITY SYMPTOMS significantly earlier and had DOG HYPERSENSITIVITY slightly more often than the subjects with a later exposure or no exposure to dog.",DOG HYPERSENSITIVITY SYMPTOMS,DOG HYPERSENSITIVITY,RO-cause_of
503729635,7/17/2014 01:24:12,,1324616471,7/17/2014 01:23:29,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,DOG HYPERSENSITIVITY SYMPTOMS causes DOG HYPERSENSITIVITY,89,89,,117,109,causes,0.964763821237732,900138-FS1-4,"However, the children who were exposed to a dog at home during early childhood developed DOG HYPERSENSITIVITY SYMPTOMS significantly earlier and had DOG HYPERSENSITIVITY slightly more often than the subjects with a later exposure or no exposure to dog.",DOG HYPERSENSITIVITY SYMPTOMS,DOG HYPERSENSITIVITY,RO-cause_of
503729635,7/17/2014 03:42:49,,1324754192,7/17/2014 03:42:20,instagc,0.7319,20183814,USA,"","",166.182.81.199,DOG HYPERSENSITIVITY causes DOG HYPERSENSITIVITY SYMPTOMS,89,89,,117,109,causes,0.964763821237732,900138-FS1-4,"However, the children who were exposed to a dog at home during early childhood developed DOG HYPERSENSITIVITY SYMPTOMS significantly earlier and had DOG HYPERSENSITIVITY slightly more often than the subjects with a later exposure or no exposure to dog.",DOG HYPERSENSITIVITY SYMPTOMS,DOG HYPERSENSITIVITY,RO-cause_of
503729635,7/17/2014 04:45:25,,1324811274,7/17/2014 04:45:14,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,DOG HYPERSENSITIVITY causes DOG HYPERSENSITIVITY SYMPTOMS,89,89,,117,109,causes,0.964763821237732,900138-FS1-4,"However, the children who were exposed to a dog at home during early childhood developed DOG HYPERSENSITIVITY SYMPTOMS significantly earlier and had DOG HYPERSENSITIVITY slightly more often than the subjects with a later exposure or no exposure to dog.",DOG HYPERSENSITIVITY SYMPTOMS,DOG HYPERSENSITIVITY,RO-cause_of
503729635,7/17/2014 06:11:24,,1324884581,7/17/2014 06:11:00,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,DOG HYPERSENSITIVITY causes DOG HYPERSENSITIVITY SYMPTOMS,89,89,,117,109,causes,0.964763821237732,900138-FS1-4,"However, the children who were exposed to a dog at home during early childhood developed DOG HYPERSENSITIVITY SYMPTOMS significantly earlier and had DOG HYPERSENSITIVITY slightly more often than the subjects with a later exposure or no exposure to dog.",DOG HYPERSENSITIVITY SYMPTOMS,DOG HYPERSENSITIVITY,RO-cause_of
503729635,7/17/2014 07:45:20,,1324979994,7/17/2014 07:45:08,instagc,0.698,18960682,GBR,"","",86.29.147.112,DOG HYPERSENSITIVITY causes DOG HYPERSENSITIVITY SYMPTOMS,89,89,,117,109,causes,0.964763821237732,900138-FS1-4,"However, the children who were exposed to a dog at home during early childhood developed DOG HYPERSENSITIVITY SYMPTOMS significantly earlier and had DOG HYPERSENSITIVITY slightly more often than the subjects with a later exposure or no exposure to dog.",DOG HYPERSENSITIVITY SYMPTOMS,DOG HYPERSENSITIVITY,RO-cause_of
503729636,7/17/2014 04:55:38,,1324820094,7/17/2014 04:55:06,prodege,0.7105,27934334,GBR,"","",86.130.153.15,GRADED PORTAL VEIN STENOSIS causes PORTAL HYPERTENSION,35,0,,61,19,causes,0.970494958830946,905126-FS1-4,PORTAL HYPERTENSION was induced by GRADED PORTAL VEIN STENOSIS whereas controls had a sham operation.,GRADED PORTAL VEIN STENOSIS,PORTAL HYPERTENSION,RO-has_finding_site
503729636,7/17/2014 06:12:19,,1324885299,7/17/2014 06:12:02,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,GRADED PORTAL VEIN STENOSIS causes PORTAL HYPERTENSION,35,0,,61,19,causes,0.970494958830946,905126-FS1-4,PORTAL HYPERTENSION was induced by GRADED PORTAL VEIN STENOSIS whereas controls had a sham operation.,GRADED PORTAL VEIN STENOSIS,PORTAL HYPERTENSION,RO-has_finding_site
503729636,7/17/2014 07:45:20,,1324980001,7/17/2014 07:45:08,instagc,0.698,18960682,GBR,"","",86.29.147.112,PORTAL HYPERTENSION causes GRADED PORTAL VEIN STENOSIS,35,0,,61,19,causes,0.970494958830946,905126-FS1-4,PORTAL HYPERTENSION was induced by GRADED PORTAL VEIN STENOSIS whereas controls had a sham operation.,GRADED PORTAL VEIN STENOSIS,PORTAL HYPERTENSION,RO-has_finding_site
503729636,7/17/2014 07:54:55,,1324990156,7/17/2014 07:54:04,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,GRADED PORTAL VEIN STENOSIS causes PORTAL HYPERTENSION,35,0,,61,19,causes,0.970494958830946,905126-FS1-4,PORTAL HYPERTENSION was induced by GRADED PORTAL VEIN STENOSIS whereas controls had a sham operation.,GRADED PORTAL VEIN STENOSIS,PORTAL HYPERTENSION,RO-has_finding_site
503729636,7/17/2014 10:35:25,,1325142655,7/17/2014 10:35:06,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,GRADED PORTAL VEIN STENOSIS causes PORTAL HYPERTENSION,35,0,,61,19,causes,0.970494958830946,905126-FS1-4,PORTAL HYPERTENSION was induced by GRADED PORTAL VEIN STENOSIS whereas controls had a sham operation.,GRADED PORTAL VEIN STENOSIS,PORTAL HYPERTENSION,RO-has_finding_site
503729636,7/17/2014 10:38:14,,1325144684,7/17/2014 10:37:53,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,GRADED PORTAL VEIN STENOSIS causes PORTAL HYPERTENSION,35,0,,61,19,causes,0.970494958830946,905126-FS1-4,PORTAL HYPERTENSION was induced by GRADED PORTAL VEIN STENOSIS whereas controls had a sham operation.,GRADED PORTAL VEIN STENOSIS,PORTAL HYPERTENSION,RO-has_finding_site
503729636,7/17/2014 10:58:26,,1325159960,7/17/2014 10:58:04,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,GRADED PORTAL VEIN STENOSIS causes PORTAL HYPERTENSION,35,0,,61,19,causes,0.970494958830946,905126-FS1-4,PORTAL HYPERTENSION was induced by GRADED PORTAL VEIN STENOSIS whereas controls had a sham operation.,GRADED PORTAL VEIN STENOSIS,PORTAL HYPERTENSION,RO-has_finding_site
503729637,7/16/2014 22:24:01,,1324510746,7/16/2014 22:23:23,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,TUBERCULIN RESPONSE diagnosed by TUBERCULOSIS,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/16/2014 22:37:24,,1324516565,7/16/2014 22:36:56,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,TUBERCULOSIS diagnosed by TUBERCULIN RESPONSE,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/16/2014 23:25:01,,1324535535,7/16/2014 23:24:47,instagc,0.7639,13763729,USA,"","",75.182.89.225,TUBERCULOSIS diagnosed by TUBERCULIN RESPONSE,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/16/2014 23:38:09,,1324541210,7/16/2014 23:37:49,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,TUBERCULOSIS diagnosed by TUBERCULIN RESPONSE,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/17/2014 06:05:27,,1324879277,7/17/2014 06:04:59,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,TUBERCULOSIS diagnosed by TUBERCULIN RESPONSE,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/17/2014 07:24:16,,1324956519,7/17/2014 07:23:17,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,TUBERCULOSIS diagnosed by TUBERCULIN RESPONSE,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/17/2014 07:57:34,,1324992920,7/17/2014 07:57:02,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729638,7/16/2014 22:37:48,,1324516759,7/16/2014 22:37:38,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,no_relation,77,50,,97,67,causes,0.609994281330419,900074-FS1-4,Rationale: ? A significant number of new cases of DIABETES MELLITUS begin as DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
503729638,7/16/2014 22:50:48,,1324521574,7/16/2014 22:50:14,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,DIABETIC KETOACIDOSIS causes DIABETES MELLITUS,77,50,,97,67,causes,0.609994281330419,900074-FS1-4,Rationale: ? A significant number of new cases of DIABETES MELLITUS begin as DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
503729638,7/16/2014 22:52:58,,1324522443,7/16/2014 22:52:38,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,77,50,,97,67,causes,0.609994281330419,900074-FS1-4,Rationale: ? A significant number of new cases of DIABETES MELLITUS begin as DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
503729638,7/16/2014 22:57:47,,1324524508,7/16/2014 22:57:01,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,DIABETIC KETOACIDOSIS causes DIABETES MELLITUS,77,50,,97,67,causes,0.609994281330419,900074-FS1-4,Rationale: ? A significant number of new cases of DIABETES MELLITUS begin as DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
503729638,7/17/2014 00:17:10,,1324557603,7/17/2014 00:16:41,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,77,50,,97,67,causes,0.609994281330419,900074-FS1-4,Rationale: ? A significant number of new cases of DIABETES MELLITUS begin as DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
503729638,7/17/2014 00:31:45,,1324567340,7/17/2014 00:31:10,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,DIABETIC KETOACIDOSIS causes DIABETES MELLITUS,77,50,,97,67,causes,0.609994281330419,900074-FS1-4,Rationale: ? A significant number of new cases of DIABETES MELLITUS begin as DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
503729638,7/17/2014 01:11:49,,1324604883,7/17/2014 01:11:24,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,DIABETIC KETOACIDOSIS causes DIABETES MELLITUS,77,50,,97,67,causes,0.609994281330419,900074-FS1-4,Rationale: ? A significant number of new cases of DIABETES MELLITUS begin as DIABETIC KETOACIDOSIS,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,RO-cause_of
503729639,7/16/2014 22:34:20,,1324515011,7/16/2014 22:34:02,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,AMYLOIDOSIS causes AMYLOID DEPOSITION,94,190,,111,201,causes,0.338061701891407,901568-FS1-4,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729639,7/17/2014 00:18:27,,1324558263,7/17/2014 00:18:06,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,94,190,,111,201,causes,0.338061701891407,901568-FS1-4,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729639,7/17/2014 07:04:37,,1324934059,7/17/2014 07:04:21,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,94,190,,111,201,causes,0.338061701891407,901568-FS1-4,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729639,7/17/2014 07:31:29,,1324964708,7/17/2014 07:30:39,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,AMYLOIDOSIS causes AMYLOID DEPOSITION,94,190,,111,201,causes,0.338061701891407,901568-FS1-4,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729639,7/17/2014 07:49:01,,1324984086,7/17/2014 07:48:15,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,no_relation,94,190,,111,201,causes,0.338061701891407,901568-FS1-4,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729639,7/17/2014 07:57:01,,1324992314,7/17/2014 07:56:08,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,AMYLOID DEPOSITION causes AMYLOIDOSIS,94,190,,111,201,causes,0.338061701891407,901568-FS1-4,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729639,7/17/2014 09:30:52,,1325084801,7/17/2014 09:30:25,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,AMYLOID DEPOSITION causes AMYLOIDOSIS,94,190,,111,201,causes,0.338061701891407,901568-FS1-4,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729640,7/16/2014 22:29:25,,1324513047,7/16/2014 22:29:16,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,MEDULLARY CARCINOMA causes COLD NODULES,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/16/2014 23:33:02,,1324538899,7/16/2014 23:32:22,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/16/2014 23:55:28,,1324547780,7/16/2014 23:55:18,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,no_relation,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/17/2014 00:18:27,,1324558259,7/17/2014 00:18:06,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/17/2014 08:48:10,,1325044823,7/17/2014 08:47:48,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,COLD NODULES causes MEDULLARY CARCINOMA,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/17/2014 09:30:55,,1325084826,7/17/2014 09:30:21,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,no_relation,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/17/2014 10:03:04,,1325115958,7/17/2014 10:02:38,prodege,0.7163,25949006,GBR,"","",62.249.242.67,no_relation,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729641,7/16/2014 22:32:54,,1324514393,7/16/2014 22:32:36,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,LATENT HYPERCORTISOLISM diagnosed by DEXAMETHASONE,232,199,,254,212,diagnosed by,0.99654575824488,906699-FS1-13,"The crucial points of the French consensus are: the usefulness of CT scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight DEXAMETHASONE test to screen for LATENT HYPERCORTISOLISM the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow up of non operated benign adrenocortical incidentalomas.",LATENT HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503729641,7/16/2014 22:45:27,,1324519509,7/16/2014 22:45:08,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,DEXAMETHASONE diagnosed by LATENT HYPERCORTISOLISM,232,199,,254,212,diagnosed by,0.99654575824488,906699-FS1-13,"The crucial points of the French consensus are: the usefulness of CT scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight DEXAMETHASONE test to screen for LATENT HYPERCORTISOLISM the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow up of non operated benign adrenocortical incidentalomas.",LATENT HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503729641,7/16/2014 23:00:35,,1324525381,7/16/2014 23:00:25,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,232,199,,254,212,diagnosed by,0.99654575824488,906699-FS1-13,"The crucial points of the French consensus are: the usefulness of CT scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight DEXAMETHASONE test to screen for LATENT HYPERCORTISOLISM the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow up of non operated benign adrenocortical incidentalomas.",LATENT HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503729641,7/16/2014 23:07:36,,1324527838,7/16/2014 23:06:47,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,LATENT HYPERCORTISOLISM diagnosed by DEXAMETHASONE,232,199,,254,212,diagnosed by,0.99654575824488,906699-FS1-13,"The crucial points of the French consensus are: the usefulness of CT scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight DEXAMETHASONE test to screen for LATENT HYPERCORTISOLISM the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow up of non operated benign adrenocortical incidentalomas.",LATENT HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503729641,7/16/2014 23:37:25,,1324540837,7/16/2014 23:36:53,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,DEXAMETHASONE diagnosed by LATENT HYPERCORTISOLISM,232,199,,254,212,diagnosed by,0.99654575824488,906699-FS1-13,"The crucial points of the French consensus are: the usefulness of CT scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight DEXAMETHASONE test to screen for LATENT HYPERCORTISOLISM the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow up of non operated benign adrenocortical incidentalomas.",LATENT HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503729641,7/16/2014 23:55:42,,1324547914,7/16/2014 23:55:29,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,LATENT HYPERCORTISOLISM diagnosed by DEXAMETHASONE,232,199,,254,212,diagnosed by,0.99654575824488,906699-FS1-13,"The crucial points of the French consensus are: the usefulness of CT scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight DEXAMETHASONE test to screen for LATENT HYPERCORTISOLISM the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow up of non operated benign adrenocortical incidentalomas.",LATENT HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503729641,7/17/2014 00:49:16,,1324583637,7/17/2014 00:49:11,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,no_relation,232,199,,254,212,diagnosed by,0.99654575824488,906699-FS1-13,"The crucial points of the French consensus are: the usefulness of CT scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight DEXAMETHASONE test to screen for LATENT HYPERCORTISOLISM the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow up of non operated benign adrenocortical incidentalomas.",LATENT HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
503729642,7/16/2014 22:36:55,,1324516279,7/16/2014 22:36:41,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,ATOPIC DIATHESIS causes ATOPIC DERMATITIS,0,56,,16,72,causes,0.993127066322841,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/16/2014 23:43:14,,1324543166,7/16/2014 23:43:05,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,ATOPIC DERMATITIS causes ATOPIC DIATHESIS,0,56,,16,72,causes,0.993127066322841,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/17/2014 00:48:43,,1324583170,7/17/2014 00:48:35,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,ATOPIC DIATHESIS causes ATOPIC DERMATITIS,0,56,,16,72,causes,0.993127066322841,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/17/2014 01:23:12,,1324615460,7/17/2014 01:22:41,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,no_relation,0,56,,16,72,causes,0.993127066322841,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/17/2014 04:44:58,,1324810864,7/17/2014 04:44:34,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,ATOPIC DERMATITIS causes ATOPIC DIATHESIS,0,56,,16,72,causes,0.993127066322841,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/17/2014 06:03:46,,1324878047,7/17/2014 06:03:06,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,no_relation,0,56,,16,72,causes,0.993127066322841,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729642,7/17/2014 06:06:04,,1324879920,7/17/2014 06:05:46,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,ATOPIC DIATHESIS causes ATOPIC DERMATITIS,0,56,,16,72,causes,0.993127066322841,900179-FS1-4,ATOPIC DERMATITIS the dermatologic manifestation of the ATOPIC DIATHESIS has a variety of clinical presentations.,ATOPIC DERMATITIS,ATOPIC DIATHESIS,RO-cause_of
503729643,7/16/2014 22:29:49,,1324513242,7/16/2014 22:29:41,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,BLADDER INJURY is location of BLADDER,150,150,,156,164,is location of,1,905349-FS1-9,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common BLADDER INJURY in children because the BLADDER lies in the abdomen.,BLADDER,BLADDER INJURY,RO-has_finding_site
503729643,7/17/2014 06:38:15,,1324908087,7/17/2014 06:37:39,instagc,0.5978,18634892,USA,"","",68.102.93.185,BLADDER is location of BLADDER INJURY,150,150,,156,164,is location of,1,905349-FS1-9,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common BLADDER INJURY in children because the BLADDER lies in the abdomen.,BLADDER,BLADDER INJURY,RO-has_finding_site
503729643,7/17/2014 07:25:17,,1324957582,7/17/2014 07:25:05,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,BLADDER is location of BLADDER INJURY,150,150,,156,164,is location of,1,905349-FS1-9,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common BLADDER INJURY in children because the BLADDER lies in the abdomen.,BLADDER,BLADDER INJURY,RO-has_finding_site
503729643,7/17/2014 07:29:14,,1324962107,7/17/2014 07:28:51,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,BLADDER INJURY is location of BLADDER,150,150,,156,164,is location of,1,905349-FS1-9,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common BLADDER INJURY in children because the BLADDER lies in the abdomen.,BLADDER,BLADDER INJURY,RO-has_finding_site
503729643,7/17/2014 09:32:24,,1325086651,7/17/2014 09:31:57,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,BLADDER is location of BLADDER INJURY,150,150,,156,164,is location of,1,905349-FS1-9,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common BLADDER INJURY in children because the BLADDER lies in the abdomen.,BLADDER,BLADDER INJURY,RO-has_finding_site
503729643,7/17/2014 10:33:16,,1325140707,7/17/2014 10:33:10,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,BLADDER is location of BLADDER INJURY,150,150,,156,164,is location of,1,905349-FS1-9,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common BLADDER INJURY in children because the BLADDER lies in the abdomen.,BLADDER,BLADDER INJURY,RO-has_finding_site
503729643,7/17/2014 10:36:28,,1325143448,7/17/2014 10:36:10,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,BLADDER is location of BLADDER INJURY,150,150,,156,164,is location of,1,905349-FS1-9,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common BLADDER INJURY in children because the BLADDER lies in the abdomen.,BLADDER,BLADDER INJURY,RO-has_finding_site
503729644,7/16/2014 22:28:51,,1324512857,7/16/2014 22:28:37,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/16/2014 23:24:55,,1324535504,7/16/2014 23:24:34,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,LOW DOSE HEPARIN PROPHYLA treats MBOLISM AFTER MA,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/17/2014 06:12:00,,1324885049,7/17/2014 06:11:42,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,no_relation,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/17/2014 07:04:50,,1324934322,7/17/2014 07:04:38,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,LOW DOSE HEPARIN PROPHYLA treats MBOLISM AFTER MA,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/17/2014 10:34:51,,1325142033,7/17/2014 10:34:32,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,LOW DOSE HEPARIN PROPHYLA treats MBOLISM AFTER MA,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/17/2014 10:38:14,,1325144683,7/17/2014 10:37:53,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729644,7/17/2014 11:00:27,,1325161576,7/17/2014 10:59:58,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,162,113,,177,138,treats,0.338061701891407,907131-FS1-2,"The object of the present investigation was to identify those who, among high risk patients, would break through LOW DOSE HEPARIN PROPHYLAxis and develop thromboeMBOLISM AFTER MAjor abdominal surgery.",MBOLISM AFTER MA,LOW DOSE HEPARIN PROPHYLA,RO-may_prevent
503729645,7/16/2014 22:25:19,,1324511165,7/16/2014 22:25:09,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,LIVER DISEASE causes INDOCYANINE GREEN (ICG UPTAKE EXCRETION,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/16/2014 22:46:42,,1324520041,7/16/2014 22:46:24,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,INDOCYANINE GREEN (ICG UPTAKE EXCRETION causes LIVER DISEASE,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/16/2014 22:53:47,,1324522852,7/16/2014 22:53:22,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,LIVER DISEASE causes INDOCYANINE GREEN (ICG UPTAKE EXCRETION,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/17/2014 00:09:30,,1324554668,7/17/2014 00:09:01,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,no_relation,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/17/2014 03:06:05,,1324718644,7/17/2014 03:05:34,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,INDOCYANINE GREEN (ICG UPTAKE EXCRETION causes LIVER DISEASE,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/17/2014 10:32:37,,1325140138,7/17/2014 10:32:28,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,INDOCYANINE GREEN (ICG UPTAKE EXCRETION causes LIVER DISEASE,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729645,7/17/2014 10:37:08,,1325143968,7/17/2014 10:36:45,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,INDOCYANINE GREEN (ICG UPTAKE EXCRETION causes LIVER DISEASE,137,70,,149,109,causes,0.802955068546966,906957-FS1-4,The purpose of the present paper is to clarify the disturbance of the INDOCYANINE GREEN (ICG UPTAKE EXCRETION mechanism in patients with LIVER DISEASE,LIVER DISEASE,INDOCYANINE GREEN (ICG UPTAKE EXCRETION,RO-may_diagnose
503729646,7/16/2014 22:23:21,,1324510484,7/16/2014 22:22:40,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,POSTMENOPAUSAL BLEEDING causes ENDOMETRIAL CANCER,161,112,,183,130,causes,0.707106781186547,902513-FS1-4,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729646,7/16/2014 22:28:26,,1324512717,7/16/2014 22:28:00,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,ENDOMETRIAL CANCER causes POSTMENOPAUSAL BLEEDING,161,112,,183,130,causes,0.707106781186547,902513-FS1-4,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729646,7/16/2014 23:12:51,,1324529808,7/16/2014 23:12:09,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,ENDOMETRIAL CANCER causes POSTMENOPAUSAL BLEEDING,161,112,,183,130,causes,0.707106781186547,902513-FS1-4,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729646,7/16/2014 23:44:34,,1324543623,7/16/2014 23:44:21,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,POSTMENOPAUSAL BLEEDING causes ENDOMETRIAL CANCER,161,112,,183,130,causes,0.707106781186547,902513-FS1-4,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729646,7/17/2014 07:44:11,,1324978695,7/17/2014 07:43:55,instagc,0.698,18960682,GBR,"","",86.29.147.112,ENDOMETRIAL CANCER causes POSTMENOPAUSAL BLEEDING,161,112,,183,130,causes,0.707106781186547,902513-FS1-4,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729646,7/17/2014 08:47:47,,1325044358,7/17/2014 08:47:25,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,POSTMENOPAUSAL BLEEDING causes ENDOMETRIAL CANCER,161,112,,183,130,causes,0.707106781186547,902513-FS1-4,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729646,7/17/2014 09:30:55,,1325084825,7/17/2014 09:30:21,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,no_relation,161,112,,183,130,causes,0.707106781186547,902513-FS1-4,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729647,7/17/2014 01:37:06,,1324629799,7/17/2014 01:36:24,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,128,158,,139,182,treats,0.957826285221151,902504-FS1-2,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and HYPERTHERMIA for unresectable HEPATOCELLULAR CARCINOMA is warranted.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729647,7/17/2014 03:06:34,,1324719144,7/17/2014 03:06:06,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,HEPATOCELLULAR CARCINOMA treats HYPERTHERMIA,128,158,,139,182,treats,0.957826285221151,902504-FS1-2,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and HYPERTHERMIA for unresectable HEPATOCELLULAR CARCINOMA is warranted.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729647,7/17/2014 08:48:50,,1325045357,7/17/2014 08:48:31,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,HEPATOCELLULAR CARCINOMA treats HYPERTHERMIA,128,158,,139,182,treats,0.957826285221151,902504-FS1-2,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and HYPERTHERMIA for unresectable HEPATOCELLULAR CARCINOMA is warranted.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729647,7/17/2014 10:33:26,,1325140834,7/17/2014 10:33:18,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,128,158,,139,182,treats,0.957826285221151,902504-FS1-2,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and HYPERTHERMIA for unresectable HEPATOCELLULAR CARCINOMA is warranted.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729647,7/17/2014 10:36:44,,1325143743,7/17/2014 10:36:17,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,128,158,,139,182,treats,0.957826285221151,902504-FS1-2,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and HYPERTHERMIA for unresectable HEPATOCELLULAR CARCINOMA is warranted.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729647,7/17/2014 10:37:26,,1325144164,7/17/2014 10:37:00,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,128,158,,139,182,treats,0.957826285221151,902504-FS1-2,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and HYPERTHERMIA for unresectable HEPATOCELLULAR CARCINOMA is warranted.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729647,7/17/2014 10:59:57,,1325161206,7/17/2014 10:59:28,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,128,158,,139,182,treats,0.957826285221151,902504-FS1-2,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and HYPERTHERMIA for unresectable HEPATOCELLULAR CARCINOMA is warranted.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729648,7/16/2014 22:24:57,,1324511018,7/16/2014 22:24:29,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,CATARACT FORMATION causes LENS TRANSPARENCY,64,18,,80,36,causes,0.990147542976674,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/16/2014 22:29:43,,1324513205,7/16/2014 22:29:07,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,no_relation,64,18,,80,36,causes,0.990147542976674,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/16/2014 23:09:47,,1324528603,7/16/2014 23:09:10,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,CATARACT FORMATION causes LENS TRANSPARENCY,64,18,,80,36,causes,0.990147542976674,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/16/2014 23:15:58,,1324530965,7/16/2014 23:15:26,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,CATARACT FORMATION causes LENS TRANSPARENCY,64,18,,80,36,causes,0.990147542976674,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/17/2014 00:18:48,,1324558427,7/17/2014 00:18:28,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,64,18,,80,36,causes,0.990147542976674,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/17/2014 04:56:25,,1324820838,7/17/2014 04:55:39,prodege,0.7105,27934334,GBR,"","",86.130.153.15,no_relation,64,18,,80,36,causes,0.990147542976674,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729648,7/17/2014 09:31:31,,1325085585,7/17/2014 09:30:56,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,CATARACT FORMATION causes LENS TRANSPARENCY,64,18,,80,36,causes,0.990147542976674,905456-FS1-4,The last stage of CATARACT FORMATION results in a total loss of LENS TRANSPARENCY and leakage of lens proteins.,LENS TRANSPARENCY,CATARACT FORMATION,RO-has_finding_site
503729649,7/16/2014 22:28:41,,1324512797,7/16/2014 22:28:32,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,no_relation,189,116,,196,127,treats,0.997054485501582,907928-FS1-2,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo controlled trial of RISPERIDONE for the treatment of aggression, agitation, and psychosis of DEMENTIA",DEMENTIA,RISPERIDONE,RO-may_treat
503729649,7/16/2014 22:49:09,,1324520922,7/16/2014 22:48:49,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,RISPERIDONE treats DEMENTIA,189,116,,196,127,treats,0.997054485501582,907928-FS1-2,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo controlled trial of RISPERIDONE for the treatment of aggression, agitation, and psychosis of DEMENTIA",DEMENTIA,RISPERIDONE,RO-may_treat
503729649,7/17/2014 00:10:39,,1324555162,7/17/2014 00:10:23,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,RISPERIDONE treats DEMENTIA,189,116,,196,127,treats,0.997054485501582,907928-FS1-2,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo controlled trial of RISPERIDONE for the treatment of aggression, agitation, and psychosis of DEMENTIA",DEMENTIA,RISPERIDONE,RO-may_treat
503729649,7/17/2014 01:36:23,,1324629102,7/17/2014 01:35:01,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,RISPERIDONE treats DEMENTIA,189,116,,196,127,treats,0.997054485501582,907928-FS1-2,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo controlled trial of RISPERIDONE for the treatment of aggression, agitation, and psychosis of DEMENTIA",DEMENTIA,RISPERIDONE,RO-may_treat
503729649,7/17/2014 02:36:20,,1324688838,7/17/2014 02:35:41,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,RISPERIDONE treats DEMENTIA,189,116,,196,127,treats,0.997054485501582,907928-FS1-2,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo controlled trial of RISPERIDONE for the treatment of aggression, agitation, and psychosis of DEMENTIA",DEMENTIA,RISPERIDONE,RO-may_treat
503729649,7/17/2014 06:12:00,,1324885050,7/17/2014 06:11:42,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,RISPERIDONE treats DEMENTIA,189,116,,196,127,treats,0.997054485501582,907928-FS1-2,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo controlled trial of RISPERIDONE for the treatment of aggression, agitation, and psychosis of DEMENTIA",DEMENTIA,RISPERIDONE,RO-may_treat
503729649,7/17/2014 10:01:01,,1325113986,7/17/2014 10:00:34,prodege,0.7163,25949006,GBR,"","",62.249.242.67,RISPERIDONE treats DEMENTIA,189,116,,196,127,treats,0.997054485501582,907928-FS1-2,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo controlled trial of RISPERIDONE for the treatment of aggression, agitation, and psychosis of DEMENTIA",DEMENTIA,RISPERIDONE,RO-may_treat
503729650,7/17/2014 03:09:57,,1324722462,7/17/2014 03:09:12,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,VARIANT ANGINA PECTORIS treats ERGONOVINE,140,223,,162,233,treats,0.959403223600247,906938-FS1-2,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729650,7/17/2014 04:44:14,,1324810057,7/17/2014 04:43:49,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,ERGONOVINE treats VARIANT ANGINA PECTORIS,140,223,,162,233,treats,0.959403223600247,906938-FS1-2,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729650,7/17/2014 07:26:59,,1324959669,7/17/2014 07:25:51,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,ERGONOVINE treats VARIANT ANGINA PECTORIS,140,223,,162,233,treats,0.959403223600247,906938-FS1-2,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729650,7/17/2014 07:46:42,,1324981436,7/17/2014 07:46:08,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,no_relation,140,223,,162,233,treats,0.959403223600247,906938-FS1-2,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729650,7/17/2014 07:56:06,,1324991474,7/17/2014 07:55:30,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,140,223,,162,233,treats,0.959403223600247,906938-FS1-2,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729650,7/17/2014 09:32:53,,1325087113,7/17/2014 09:32:35,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,ERGONOVINE treats VARIANT ANGINA PECTORIS,140,223,,162,233,treats,0.959403223600247,906938-FS1-2,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729650,7/17/2014 10:33:44,,1325141149,7/17/2014 10:33:35,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,ERGONOVINE treats VARIANT ANGINA PECTORIS,140,223,,162,233,treats,0.959403223600247,906938-FS1-2,Transient prolongation of the corrected Q T interval preceded spontaneous or ergonovine maleate provoked coronary spasm in 11 patients with VARIANT ANGINA PECTORIS whereas no significant change in the Q T interval followed ERGONOVINE administration in 27 control patients with atypical chest pain who did not have coronary spasm.,VARIANT ANGINA PECTORIS,ERGONOVINE,RO-may_diagnose
503729651,7/16/2014 22:32:35,,1324514278,7/16/2014 22:32:02,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,33,86,,59,109,is location of,0.508000508000762,901556-FS1-9,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729651,7/16/2014 22:37:38,,1324516696,7/16/2014 22:37:25,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,GLIOBLASTOMA MULTIFORME is location of MICROVASCULAR PROLIFERATION,33,86,,59,109,is location of,0.508000508000762,901556-FS1-9,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729651,7/16/2014 23:00:47,,1324525441,7/16/2014 23:00:36,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,33,86,,59,109,is location of,0.508000508000762,901556-FS1-9,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729651,7/16/2014 23:43:31,,1324543254,7/16/2014 23:43:02,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,GLIOBLASTOMA MULTIFORME is location of MICROVASCULAR PROLIFERATION,33,86,,59,109,is location of,0.508000508000762,901556-FS1-9,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729651,7/17/2014 01:32:39,,1324625261,7/17/2014 01:32:33,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,MICROVASCULAR PROLIFERATION is location of GLIOBLASTOMA MULTIFORME,33,86,,59,109,is location of,0.508000508000762,901556-FS1-9,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729651,7/17/2014 01:36:23,,1324629101,7/17/2014 01:35:01,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,no_relation,33,86,,59,109,is location of,0.508000508000762,901556-FS1-9,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729651,7/17/2014 09:32:15,,1325086475,7/17/2014 09:31:47,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,MICROVASCULAR PROLIFERATION is location of GLIOBLASTOMA MULTIFORME,33,86,,59,109,is location of,0.508000508000762,901556-FS1-9,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729652,7/16/2014 22:50:13,,1324521278,7/16/2014 22:49:49,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,OXYGEN treats DECOMPRESSION SICKNESS,43,84,,64,90,treats,0.447213595499958,908185-FS1-2,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729652,7/16/2014 23:00:02,,1324525247,7/16/2014 22:59:38,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,OXYGEN treats DECOMPRESSION SICKNESS,43,84,,64,90,treats,0.447213595499958,908185-FS1-2,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729652,7/16/2014 23:08:02,,1324528023,7/16/2014 23:07:37,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,43,84,,64,90,treats,0.447213595499958,908185-FS1-2,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729652,7/17/2014 00:10:22,,1324555013,7/17/2014 00:09:56,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,no_relation,43,84,,64,90,treats,0.447213595499958,908185-FS1-2,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729652,7/17/2014 01:14:26,,1324607197,7/17/2014 01:13:47,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,OXYGEN treats DECOMPRESSION SICKNESS,43,84,,64,90,treats,0.447213595499958,908185-FS1-2,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729652,7/17/2014 01:38:04,,1324630892,7/17/2014 01:37:38,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,OXYGEN treats DECOMPRESSION SICKNESS,43,84,,64,90,treats,0.447213595499958,908185-FS1-2,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729652,7/17/2014 02:34:58,,1324687343,7/17/2014 02:34:21,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,OXYGEN treats DECOMPRESSION SICKNESS,43,84,,64,90,treats,0.447213595499958,908185-FS1-2,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729653,7/16/2014 22:33:17,,1324514547,7/16/2014 22:32:56,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,MAGNESIUM DEFICIENCY diagnosed by MAGNESIUM TOLERANCE TEST,17,107,,36,131,diagnosed by,0.987878339907213,907157-FS1-13,"The diagnosis of MAGNESIUM DEFICIENCY is usually made by a low serum magnesium concentration, although the MAGNESIUM TOLERANCE TEST may be more indicative of low magnesium states.",MAGNESIUM DEFICIENCY,MAGNESIUM TOLERANCE TEST,RO-may_prevent
503729653,7/16/2014 22:37:48,,1324516758,7/16/2014 22:37:38,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,MAGNESIUM DEFICIENCY diagnosed by MAGNESIUM TOLERANCE TEST,17,107,,36,131,diagnosed by,0.987878339907213,907157-FS1-13,"The diagnosis of MAGNESIUM DEFICIENCY is usually made by a low serum magnesium concentration, although the MAGNESIUM TOLERANCE TEST may be more indicative of low magnesium states.",MAGNESIUM DEFICIENCY,MAGNESIUM TOLERANCE TEST,RO-may_prevent
503729653,7/16/2014 23:55:42,,1324547917,7/16/2014 23:55:29,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,MAGNESIUM DEFICIENCY diagnosed by MAGNESIUM TOLERANCE TEST,17,107,,36,131,diagnosed by,0.987878339907213,907157-FS1-13,"The diagnosis of MAGNESIUM DEFICIENCY is usually made by a low serum magnesium concentration, although the MAGNESIUM TOLERANCE TEST may be more indicative of low magnesium states.",MAGNESIUM DEFICIENCY,MAGNESIUM TOLERANCE TEST,RO-may_prevent
503729653,7/17/2014 00:28:11,,1324564395,7/17/2014 00:27:51,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,MAGNESIUM DEFICIENCY diagnosed by MAGNESIUM TOLERANCE TEST,17,107,,36,131,diagnosed by,0.987878339907213,907157-FS1-13,"The diagnosis of MAGNESIUM DEFICIENCY is usually made by a low serum magnesium concentration, although the MAGNESIUM TOLERANCE TEST may be more indicative of low magnesium states.",MAGNESIUM DEFICIENCY,MAGNESIUM TOLERANCE TEST,RO-may_prevent
503729653,7/17/2014 00:48:43,,1324583169,7/17/2014 00:48:35,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,MAGNESIUM TOLERANCE TEST diagnosed by MAGNESIUM DEFICIENCY,17,107,,36,131,diagnosed by,0.987878339907213,907157-FS1-13,"The diagnosis of MAGNESIUM DEFICIENCY is usually made by a low serum magnesium concentration, although the MAGNESIUM TOLERANCE TEST may be more indicative of low magnesium states.",MAGNESIUM DEFICIENCY,MAGNESIUM TOLERANCE TEST,RO-may_prevent
503729653,7/17/2014 03:41:44,,1324753173,7/17/2014 03:41:30,instagc,0.7319,20183814,USA,"","",166.182.81.199,MAGNESIUM DEFICIENCY diagnosed by MAGNESIUM TOLERANCE TEST,17,107,,36,131,diagnosed by,0.987878339907213,907157-FS1-13,"The diagnosis of MAGNESIUM DEFICIENCY is usually made by a low serum magnesium concentration, although the MAGNESIUM TOLERANCE TEST may be more indicative of low magnesium states.",MAGNESIUM DEFICIENCY,MAGNESIUM TOLERANCE TEST,RO-may_prevent
503729653,7/17/2014 06:06:04,,1324879918,7/17/2014 06:05:46,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,MAGNESIUM DEFICIENCY diagnosed by MAGNESIUM TOLERANCE TEST,17,107,,36,131,diagnosed by,0.987878339907213,907157-FS1-13,"The diagnosis of MAGNESIUM DEFICIENCY is usually made by a low serum magnesium concentration, although the MAGNESIUM TOLERANCE TEST may be more indicative of low magnesium states.",MAGNESIUM DEFICIENCY,MAGNESIUM TOLERANCE TEST,RO-may_prevent
503729654,7/16/2014 22:57:00,,1324524253,7/16/2014 22:56:42,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,ARSENIC TRIOXIDE treats PROMYELOCYTIC LEUKEMIA (APML),85,145,,113,161,treats,0.987878339907213,908298-FS1-2,A total of 11 children (five males and six females) with hypergranular type of acute PROMYELOCYTIC LEUKEMIA (APML) were treated with intravenous ARSENIC TRIOXIDE (As(2)O(3)) between December 1998 and October 2003.,PROMYELOCYTIC LEUKEMIA (APML),ARSENIC TRIOXIDE,RO-may_treat
503729654,7/17/2014 01:32:09,,1324624847,7/17/2014 01:31:59,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,PROMYELOCYTIC LEUKEMIA (APML) treats ARSENIC TRIOXIDE,85,145,,113,161,treats,0.987878339907213,908298-FS1-2,A total of 11 children (five males and six females) with hypergranular type of acute PROMYELOCYTIC LEUKEMIA (APML) were treated with intravenous ARSENIC TRIOXIDE (As(2)O(3)) between December 1998 and October 2003.,PROMYELOCYTIC LEUKEMIA (APML),ARSENIC TRIOXIDE,RO-may_treat
503729654,7/17/2014 04:57:30,,1324821838,7/17/2014 04:57:07,prodege,0.7105,27934334,GBR,"","",86.130.153.15,ARSENIC TRIOXIDE treats PROMYELOCYTIC LEUKEMIA (APML),85,145,,113,161,treats,0.987878339907213,908298-FS1-2,A total of 11 children (five males and six females) with hypergranular type of acute PROMYELOCYTIC LEUKEMIA (APML) were treated with intravenous ARSENIC TRIOXIDE (As(2)O(3)) between December 1998 and October 2003.,PROMYELOCYTIC LEUKEMIA (APML),ARSENIC TRIOXIDE,RO-may_treat
503729654,7/17/2014 06:12:36,,1324885498,7/17/2014 06:12:19,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,ARSENIC TRIOXIDE treats PROMYELOCYTIC LEUKEMIA (APML),85,145,,113,161,treats,0.987878339907213,908298-FS1-2,A total of 11 children (five males and six females) with hypergranular type of acute PROMYELOCYTIC LEUKEMIA (APML) were treated with intravenous ARSENIC TRIOXIDE (As(2)O(3)) between December 1998 and October 2003.,PROMYELOCYTIC LEUKEMIA (APML),ARSENIC TRIOXIDE,RO-may_treat
503729654,7/17/2014 07:04:50,,1324934323,7/17/2014 07:04:38,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,ARSENIC TRIOXIDE treats PROMYELOCYTIC LEUKEMIA (APML),85,145,,113,161,treats,0.987878339907213,908298-FS1-2,A total of 11 children (five males and six females) with hypergranular type of acute PROMYELOCYTIC LEUKEMIA (APML) were treated with intravenous ARSENIC TRIOXIDE (As(2)O(3)) between December 1998 and October 2003.,PROMYELOCYTIC LEUKEMIA (APML),ARSENIC TRIOXIDE,RO-may_treat
503729654,7/17/2014 07:25:03,,1324957311,7/17/2014 07:24:17,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,ARSENIC TRIOXIDE treats PROMYELOCYTIC LEUKEMIA (APML),85,145,,113,161,treats,0.987878339907213,908298-FS1-2,A total of 11 children (five males and six females) with hypergranular type of acute PROMYELOCYTIC LEUKEMIA (APML) were treated with intravenous ARSENIC TRIOXIDE (As(2)O(3)) between December 1998 and October 2003.,PROMYELOCYTIC LEUKEMIA (APML),ARSENIC TRIOXIDE,RO-may_treat
503729654,7/17/2014 09:31:14,,1325085229,7/17/2014 09:30:54,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,ARSENIC TRIOXIDE treats PROMYELOCYTIC LEUKEMIA (APML),85,145,,113,161,treats,0.987878339907213,908298-FS1-2,A total of 11 children (five males and six females) with hypergranular type of acute PROMYELOCYTIC LEUKEMIA (APML) were treated with intravenous ARSENIC TRIOXIDE (As(2)O(3)) between December 1998 and October 2003.,PROMYELOCYTIC LEUKEMIA (APML),ARSENIC TRIOXIDE,RO-may_treat
503729655,7/16/2014 23:26:14,,1324536040,7/16/2014 23:25:58,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,EPILEPSY causes NUMBER OF SEIZURES,101,47,,118,55,causes,0.904534033733291,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/16/2014 23:47:27,,1324544682,7/16/2014 23:46:16,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,EPILEPSY causes NUMBER OF SEIZURES,101,47,,118,55,causes,0.904534033733291,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/16/2014 23:54:59,,1324547590,7/16/2014 23:54:46,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,EPILEPSY causes NUMBER OF SEIZURES,101,47,,118,55,causes,0.904534033733291,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/17/2014 00:09:55,,1324554835,7/17/2014 00:09:31,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,no_relation,101,47,,118,55,causes,0.904534033733291,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/17/2014 01:32:15,,1324624926,7/17/2014 01:32:10,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,NUMBER OF SEIZURES causes EPILEPSY,101,47,,118,55,causes,0.904534033733291,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/17/2014 01:37:06,,1324629798,7/17/2014 01:36:24,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,no_relation,101,47,,118,55,causes,0.904534033733291,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729655,7/17/2014 07:48:15,,1324983134,7/17/2014 07:47:28,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,no_relation,101,47,,118,55,causes,0.904534033733291,904527-FS1-4,Menopause tends to occur earlier in women with EPILEPSY especially in the setting of a high lifetime NUMBER OF SEIZURES and lifetime use of multiple enzyme inducing AEDs.,NUMBER OF SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503729656,7/16/2014 22:46:42,,1324520037,7/16/2014 22:46:24,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY treats ADRENALINE INDUCED ARRHYTHMIA,162,122,,190,158,treats,0.668153104781061,907226-FS1-2,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729656,7/16/2014 23:25:29,,1324535731,7/16/2014 23:25:02,instagc,0.7639,13763729,USA,"","",75.182.89.225,no_relation,162,122,,190,158,treats,0.668153104781061,907226-FS1-2,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729656,7/17/2014 00:48:49,,1324583212,7/17/2014 00:48:44,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY treats ADRENALINE INDUCED ARRHYTHMIA,162,122,,190,158,treats,0.668153104781061,907226-FS1-2,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729656,7/17/2014 09:31:46,,1325085902,7/17/2014 09:31:14,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,no_relation,162,122,,190,158,treats,0.668153104781061,907226-FS1-2,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729656,7/17/2014 10:33:26,,1325140827,7/17/2014 10:33:18,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,162,122,,190,158,treats,0.668153104781061,907226-FS1-2,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729656,7/17/2014 10:36:59,,1325143918,7/17/2014 10:36:29,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,162,122,,190,158,treats,0.668153104781061,907226-FS1-2,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729656,7/17/2014 10:37:08,,1325143969,7/17/2014 10:36:45,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY treats ADRENALINE INDUCED ARRHYTHMIA,162,122,,190,158,treats,0.668153104781061,907226-FS1-2,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729657,7/16/2014 22:32:00,,1324514086,7/16/2014 22:31:11,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,AMYLOID DEPOSITION is location of AMYLOIDOSIS,94,190,,111,201,is location of,0.50709255283711,901568-FS1-9,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729657,7/16/2014 22:45:27,,1324519510,7/16/2014 22:45:08,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,AMYLOID DEPOSITION is location of AMYLOIDOSIS,94,190,,111,201,is location of,0.50709255283711,901568-FS1-9,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729657,7/16/2014 23:43:04,,1324543119,7/16/2014 23:42:53,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,AMYLOID DEPOSITION is location of AMYLOIDOSIS,94,190,,111,201,is location of,0.50709255283711,901568-FS1-9,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729657,7/17/2014 01:13:20,,1324606265,7/17/2014 01:12:52,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,no_relation,94,190,,111,201,is location of,0.50709255283711,901568-FS1-9,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729657,7/17/2014 03:09:00,,1324721657,7/17/2014 03:08:33,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,AMYLOIDOSIS is location of AMYLOID DEPOSITION,94,190,,111,201,is location of,0.50709255283711,901568-FS1-9,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729657,7/17/2014 07:57:34,,1324992918,7/17/2014 07:57:02,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,94,190,,111,201,is location of,0.50709255283711,901568-FS1-9,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729657,7/17/2014 10:32:27,,1325140007,7/17/2014 10:32:18,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,94,190,,111,201,is location of,0.50709255283711,901568-FS1-9,Our observations and descriptions in the literature indicate that the presence and degrees of AMYLOID DEPOSITION in the skeletal muscles would be related to the types of amyloid proteins in AMYLOIDOSIS,AMYLOID DEPOSITION,AMYLOIDOSIS,RO-disease_has_finding
503729658,7/16/2014 22:26:51,,1324511894,7/16/2014 22:26:32,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,92,57,,106,70,causes,0.311085508419128,905415-FS1-4,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729658,7/16/2014 22:49:48,,1324521181,7/16/2014 22:49:10,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,SMALL INTESTINE causes MALABSORPTION,92,57,,106,70,causes,0.311085508419128,905415-FS1-4,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729658,7/16/2014 22:51:49,,1324522018,7/16/2014 22:51:31,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,92,57,,106,70,causes,0.311085508419128,905415-FS1-4,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729658,7/16/2014 22:56:01,,1324523843,7/16/2014 22:55:27,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,92,57,,106,70,causes,0.311085508419128,905415-FS1-4,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729658,7/17/2014 00:17:10,,1324557602,7/17/2014 00:16:41,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,92,57,,106,70,causes,0.311085508419128,905415-FS1-4,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729658,7/17/2014 00:34:07,,1324569237,7/17/2014 00:33:41,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,92,57,,106,70,causes,0.311085508419128,905415-FS1-4,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729658,7/17/2014 03:06:05,,1324718658,7/17/2014 03:05:34,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,SMALL INTESTINE causes MALABSORPTION,92,57,,106,70,causes,0.311085508419128,905415-FS1-4,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729659,7/16/2014 23:08:38,,1324528216,7/16/2014 23:08:02,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,142,0,,153,30,is location of,0.890870806374748,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 00:27:08,,1324563441,7/17/2014 00:26:50,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,UPPER AIRWAY is location of OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,is location of,0.890870806374748,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 01:11:49,,1324604884,7/17/2014 01:11:24,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,UPPER AIRWAY is location of OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,is location of,0.890870806374748,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 01:38:50,,1324631741,7/17/2014 01:38:07,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,UPPER AIRWAY is location of OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,is location of,0.890870806374748,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 03:41:05,,1324752619,7/17/2014 03:40:41,instagc,0.7319,20183814,USA,"","",166.182.81.199,UPPER AIRWAY is location of OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,is location of,0.890870806374748,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 06:11:41,,1324884840,7/17/2014 06:11:26,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,UPPER AIRWAY is location of OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,is location of,0.890870806374748,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 07:24:16,,1324956517,7/17/2014 07:23:17,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,no_relation,142,0,,153,30,is location of,0.890870806374748,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729660,7/16/2014 22:26:51,,1324511896,7/16/2014 22:26:32,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.995893206467704,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 00:28:11,,1324564377,7/17/2014 00:27:51,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.995893206467704,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 02:18:09,,1324670134,7/17/2014 02:17:56,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.995893206467704,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 03:06:34,,1324719151,7/17/2014 03:06:06,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.995893206467704,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 07:04:58,,1324934504,7/17/2014 07:04:51,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.995893206467704,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 07:46:42,,1324981439,7/17/2014 07:46:08,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.995893206467704,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729660,7/17/2014 09:32:53,,1325087104,7/17/2014 09:32:35,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,CLINDAMYCIN treats BACTERIAL VAGINOSIS,53,0,,71,11,treats,0.995893206467704,907536-FS1-2,CLINDAMYCIN versus metronidazole in the treatment of BACTERIAL VAGINOSIS,BACTERIAL VAGINOSIS,CLINDAMYCIN,RO-may_treat
503729661,7/16/2014 23:33:53,,1324539217,7/16/2014 23:33:37,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/16/2014 23:55:16,,1324547692,7/16/2014 23:55:00,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/17/2014 00:02:37,,1324551650,7/17/2014 00:02:12,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/17/2014 03:09:28,,1324722081,7/17/2014 03:09:00,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/17/2014 07:25:49,,1324958270,7/17/2014 07:25:18,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/17/2014 10:03:33,,1325116452,7/17/2014 10:03:05,prodege,0.7163,25949006,GBR,"","",62.249.242.67,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/17/2014 10:32:47,,1325140284,7/17/2014 10:32:38,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,TUBERCULIN RESPONSE treats TUBERCULOSIS,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729662,7/16/2014 23:25:58,,1324535931,7/16/2014 23:25:41,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,SMALL INTESTINE is location of MALABSORPTION,92,57,,106,70,is location of,0.933256525257383,905415-FS1-9,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729662,7/17/2014 01:26:14,,1324618361,7/17/2014 01:25:37,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,SMALL INTESTINE is location of MALABSORPTION,92,57,,106,70,is location of,0.933256525257383,905415-FS1-9,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729662,7/17/2014 01:32:45,,1324625391,7/17/2014 01:32:39,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,SMALL INTESTINE is location of MALABSORPTION,92,57,,106,70,is location of,0.933256525257383,905415-FS1-9,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729662,7/17/2014 03:11:47,,1324724165,7/17/2014 03:11:26,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,SMALL INTESTINE is location of MALABSORPTION,92,57,,106,70,is location of,0.933256525257383,905415-FS1-9,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729662,7/17/2014 07:04:58,,1324934503,7/17/2014 07:04:51,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,SMALL INTESTINE is location of MALABSORPTION,92,57,,106,70,is location of,0.933256525257383,905415-FS1-9,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729662,7/17/2014 07:30:38,,1324963860,7/17/2014 07:30:04,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,SMALL INTESTINE is location of MALABSORPTION,92,57,,106,70,is location of,0.933256525257383,905415-FS1-9,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729662,7/17/2014 09:31:56,,1325086064,7/17/2014 09:31:33,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,SMALL INTESTINE is location of MALABSORPTION,92,57,,106,70,is location of,0.933256525257383,905415-FS1-9,"Gastrografin accelerated small bowel transit, leading to MALABSORPTION of the xylose in the SMALL INTESTINE and subsequent colonic metabolism of the xylose.",SMALL INTESTINE,MALABSORPTION,RO-has_finding_site
503729663,7/16/2014 22:25:32,,1324511259,7/16/2014 22:24:58,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,no_relation,109,135,,117,149,causes,0.643267520902677,902781-FS1-4,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as HEMATURIA or a history of BLADDER CANCER.",HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
503729663,7/16/2014 22:32:54,,1324514394,7/16/2014 22:32:36,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,109,135,,117,149,causes,0.643267520902677,902781-FS1-4,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as HEMATURIA or a history of BLADDER CANCER.",HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
503729663,7/16/2014 22:53:20,,1324522626,7/16/2014 22:53:00,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,BLADDER CANCER causes HEMATURIA,109,135,,117,149,causes,0.643267520902677,902781-FS1-4,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as HEMATURIA or a history of BLADDER CANCER.",HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
503729663,7/16/2014 22:56:01,,1324523844,7/16/2014 22:55:27,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,BLADDER CANCER causes HEMATURIA,109,135,,117,149,causes,0.643267520902677,902781-FS1-4,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as HEMATURIA or a history of BLADDER CANCER.",HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
503729663,7/16/2014 23:32:21,,1324538630,7/16/2014 23:31:55,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,109,135,,117,149,causes,0.643267520902677,902781-FS1-4,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as HEMATURIA or a history of BLADDER CANCER.",HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
503729663,7/17/2014 00:02:37,,1324551651,7/17/2014 00:02:12,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,no_relation,109,135,,117,149,causes,0.643267520902677,902781-FS1-4,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as HEMATURIA or a history of BLADDER CANCER.",HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
503729663,7/17/2014 00:34:07,,1324569251,7/17/2014 00:33:41,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,BLADDER CANCER causes HEMATURIA,109,135,,117,149,causes,0.643267520902677,902781-FS1-4,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as HEMATURIA or a history of BLADDER CANCER.",HEMATURIA,BLADDER CANCER,RO-disease_may_have_finding
503729664,7/16/2014 22:33:17,,1324514544,7/16/2014 22:32:56,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,137,208,,160,220,treats,0.437594974493684,904540-FS1-2,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729664,7/16/2014 23:25:40,,1324535802,7/16/2014 23:25:18,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,no_relation,137,208,,160,220,treats,0.437594974493684,904540-FS1-2,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729664,7/17/2014 00:32:24,,1324567736,7/17/2014 00:31:47,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,BLOOD PRESSURE ELEVATION treats HYPERTENSION,137,208,,160,220,treats,0.437594974493684,904540-FS1-2,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729664,7/17/2014 03:41:05,,1324752620,7/17/2014 03:40:41,instagc,0.7319,20183814,USA,"","",166.182.81.199,no_relation,137,208,,160,220,treats,0.437594974493684,904540-FS1-2,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729664,7/17/2014 04:45:12,,1324811114,7/17/2014 04:44:59,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,BLOOD PRESSURE ELEVATION treats HYPERTENSION,137,208,,160,220,treats,0.437594974493684,904540-FS1-2,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729664,7/17/2014 06:11:41,,1324884838,7/17/2014 06:11:26,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,HYPERTENSION treats BLOOD PRESSURE ELEVATION,137,208,,160,220,treats,0.437594974493684,904540-FS1-2,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729664,7/17/2014 06:39:05,,1324908910,7/17/2014 06:38:34,instagc,0.5978,18634892,USA,"","",68.102.93.185,no_relation,137,208,,160,220,treats,0.437594974493684,904540-FS1-2,Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga null mice with Cts prevents BLOOD PRESSURE ELEVATION indicating a direct role of Cts in preventing HYPERTENSION,BLOOD PRESSURE ELEVATION,HYPERTENSION,RO-has_definitional_manifestation
503729665,7/16/2014 22:29:09,,1324512961,7/16/2014 22:28:49,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,FIRST LINE ANTITUBERCULOSIS DRUGS treats MYCOBACTERIUM TUBERCULOSIS,124,180,,149,213,treats,0.957826285221151,907849-FS1-2,"Ruiz Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   MYCOBACTERIUM TUBERCULOSIS  susceptible or resistant to FIRST LINE ANTITUBERCULOSIS DRUGS.",MYCOBACTERIUM TUBERCULOSIS,FIRST LINE ANTITUBERCULOSIS DRUGS,RO-may_treat
503729665,7/16/2014 22:29:13,,1324512977,7/16/2014 22:29:02,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,FIRST LINE ANTITUBERCULOSIS DRUGS treats MYCOBACTERIUM TUBERCULOSIS,124,180,,149,213,treats,0.957826285221151,907849-FS1-2,"Ruiz Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   MYCOBACTERIUM TUBERCULOSIS  susceptible or resistant to FIRST LINE ANTITUBERCULOSIS DRUGS.",MYCOBACTERIUM TUBERCULOSIS,FIRST LINE ANTITUBERCULOSIS DRUGS,RO-may_treat
503729665,7/16/2014 22:36:55,,1324516278,7/16/2014 22:36:41,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,no_relation,124,180,,149,213,treats,0.957826285221151,907849-FS1-2,"Ruiz Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   MYCOBACTERIUM TUBERCULOSIS  susceptible or resistant to FIRST LINE ANTITUBERCULOSIS DRUGS.",MYCOBACTERIUM TUBERCULOSIS,FIRST LINE ANTITUBERCULOSIS DRUGS,RO-may_treat
503729665,7/16/2014 22:57:00,,1324524254,7/16/2014 22:56:42,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,FIRST LINE ANTITUBERCULOSIS DRUGS treats MYCOBACTERIUM TUBERCULOSIS,124,180,,149,213,treats,0.957826285221151,907849-FS1-2,"Ruiz Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   MYCOBACTERIUM TUBERCULOSIS  susceptible or resistant to FIRST LINE ANTITUBERCULOSIS DRUGS.",MYCOBACTERIUM TUBERCULOSIS,FIRST LINE ANTITUBERCULOSIS DRUGS,RO-may_treat
503729665,7/17/2014 00:27:08,,1324563447,7/17/2014 00:26:50,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,FIRST LINE ANTITUBERCULOSIS DRUGS treats MYCOBACTERIUM TUBERCULOSIS,124,180,,149,213,treats,0.957826285221151,907849-FS1-2,"Ruiz Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   MYCOBACTERIUM TUBERCULOSIS  susceptible or resistant to FIRST LINE ANTITUBERCULOSIS DRUGS.",MYCOBACTERIUM TUBERCULOSIS,FIRST LINE ANTITUBERCULOSIS DRUGS,RO-may_treat
503729665,7/17/2014 02:35:40,,1324688035,7/17/2014 02:35:02,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,FIRST LINE ANTITUBERCULOSIS DRUGS treats MYCOBACTERIUM TUBERCULOSIS,124,180,,149,213,treats,0.957826285221151,907849-FS1-2,"Ruiz Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   MYCOBACTERIUM TUBERCULOSIS  susceptible or resistant to FIRST LINE ANTITUBERCULOSIS DRUGS.",MYCOBACTERIUM TUBERCULOSIS,FIRST LINE ANTITUBERCULOSIS DRUGS,RO-may_treat
503729665,7/17/2014 07:27:14,,1324959935,7/17/2014 07:27:00,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,FIRST LINE ANTITUBERCULOSIS DRUGS treats MYCOBACTERIUM TUBERCULOSIS,124,180,,149,213,treats,0.957826285221151,907849-FS1-2,"Ruiz Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   MYCOBACTERIUM TUBERCULOSIS  susceptible or resistant to FIRST LINE ANTITUBERCULOSIS DRUGS.",MYCOBACTERIUM TUBERCULOSIS,FIRST LINE ANTITUBERCULOSIS DRUGS,RO-may_treat
503729666,7/16/2014 22:25:08,,1324511111,7/16/2014 22:24:50,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/16/2014 22:55:26,,1324523601,7/16/2014 22:54:36,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/17/2014 01:12:50,,1324605879,7/17/2014 01:11:49,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/17/2014 02:17:55,,1324669907,7/17/2014 02:17:41,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/17/2014 02:36:20,,1324688836,7/17/2014 02:35:41,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/17/2014 03:10:36,,1324723071,7/17/2014 03:10:21,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,ALUMINUM INTOXICATION causes ALUMINUM,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729666,7/17/2014 03:11:25,,1324723739,7/17/2014 03:10:46,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,ALUMINUM causes ALUMINUM INTOXICATION,0,0,,7,21,causes,0.843274042711568,903967-FS1-4,ALUMINUM INTOXICATION is common in patients with chronic renal failure because of absorption of aluminum during dialysis from ALUMINUM containing dyalysate water and ingestion of phosphate binders containing aluminum.,ALUMINUM,ALUMINUM INTOXICATION,RO-has_causative_agent
503729667,7/16/2014 22:28:59,,1324512881,7/16/2014 22:28:44,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,no_relation,339,306,,366,317,treats,0.991836598134176,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/16/2014 23:26:51,,1324536292,7/16/2014 23:26:35,instagc,0.7639,13763729,USA,"","",75.182.89.225,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.991836598134176,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/17/2014 01:14:26,,1324607198,7/17/2014 01:13:47,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.991836598134176,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/17/2014 06:38:33,,1324908402,7/17/2014 06:38:17,instagc,0.5978,18634892,USA,"","",68.102.93.185,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.991836598134176,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/17/2014 08:47:47,,1325044357,7/17/2014 08:47:25,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.991836598134176,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/17/2014 09:32:33,,1325086782,7/17/2014 09:32:16,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.991836598134176,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/17/2014 10:35:40,,1325142870,7/17/2014 10:35:26,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.991836598134176,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729668,7/16/2014 22:46:22,,1324519907,7/16/2014 22:46:07,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,ENDOMETRIAL CANCER diagnosed by POSTMENOPAUSAL BLEEDING,161,112,,183,130,diagnosed by,0.424264068711929,902513-FS1-13,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729668,7/16/2014 23:09:24,,1324528456,7/16/2014 23:08:39,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,161,112,,183,130,diagnosed by,0.424264068711929,902513-FS1-13,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729668,7/17/2014 03:42:49,,1324754193,7/17/2014 03:42:20,instagc,0.7319,20183814,USA,"","",166.182.81.199,ENDOMETRIAL CANCER diagnosed by POSTMENOPAUSAL BLEEDING,161,112,,183,130,diagnosed by,0.424264068711929,902513-FS1-13,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729668,7/17/2014 07:44:39,,1324979203,7/17/2014 07:44:29,instagc,0.698,18960682,GBR,"","",86.29.147.112,ENDOMETRIAL CANCER diagnosed by POSTMENOPAUSAL BLEEDING,161,112,,183,130,diagnosed by,0.424264068711929,902513-FS1-13,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729668,7/17/2014 08:32:26,,1325032571,7/17/2014 08:31:43,prodege,0.5179,12641652,GBR,S9,Newry,31.48.14.129,ENDOMETRIAL CANCER diagnosed by POSTMENOPAUSAL BLEEDING,161,112,,183,130,diagnosed by,0.424264068711929,902513-FS1-13,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729668,7/17/2014 09:31:46,,1325085903,7/17/2014 09:31:14,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,ENDOMETRIAL CANCER diagnosed by POSTMENOPAUSAL BLEEDING,161,112,,183,130,diagnosed by,0.424264068711929,902513-FS1-13,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729668,7/17/2014 10:36:44,,1325143744,7/17/2014 10:36:17,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,ENDOMETRIAL CANCER diagnosed by POSTMENOPAUSAL BLEEDING,161,112,,183,130,diagnosed by,0.424264068711929,902513-FS1-13,? A prospective study was done to evaluate the role of three dimensional vs. two dimensional TVUS in diagnosing ENDOMETRIAL CANCER in patients with a history of POSTMENOPAUSAL BLEEDING,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,RO-disease_may_have_finding
503729669,7/16/2014 23:00:02,,1324525244,7/16/2014 22:59:38,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,LIDOCAINE treats PAIN,78,42,,81,51,treats,0.989743318610787,907174-FS1-2,This study concluded that the addition of LIDOCAINE significantly reduced the PAIN felt in the circulatory tract selected for the injection of propofol.,PAIN,LIDOCAINE,RO-may_prevent
503729669,7/16/2014 23:33:20,,1324538989,7/16/2014 23:33:03,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,LIDOCAINE treats PAIN,78,42,,81,51,treats,0.989743318610787,907174-FS1-2,This study concluded that the addition of LIDOCAINE significantly reduced the PAIN felt in the circulatory tract selected for the injection of propofol.,PAIN,LIDOCAINE,RO-may_prevent
503729669,7/16/2014 23:44:34,,1324543621,7/16/2014 23:44:21,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,LIDOCAINE treats PAIN,78,42,,81,51,treats,0.989743318610787,907174-FS1-2,This study concluded that the addition of LIDOCAINE significantly reduced the PAIN felt in the circulatory tract selected for the injection of propofol.,PAIN,LIDOCAINE,RO-may_prevent
503729669,7/17/2014 03:05:32,,1324718118,7/17/2014 03:05:04,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,LIDOCAINE treats PAIN,78,42,,81,51,treats,0.989743318610787,907174-FS1-2,This study concluded that the addition of LIDOCAINE significantly reduced the PAIN felt in the circulatory tract selected for the injection of propofol.,PAIN,LIDOCAINE,RO-may_prevent
503729669,7/17/2014 07:55:28,,1324990755,7/17/2014 07:54:56,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,LIDOCAINE treats PAIN,78,42,,81,51,treats,0.989743318610787,907174-FS1-2,This study concluded that the addition of LIDOCAINE significantly reduced the PAIN felt in the circulatory tract selected for the injection of propofol.,PAIN,LIDOCAINE,RO-may_prevent
503729669,7/17/2014 10:02:18,,1325115211,7/17/2014 10:01:39,prodege,0.7163,25949006,GBR,"","",62.249.242.67,LIDOCAINE treats PAIN,78,42,,81,51,treats,0.989743318610787,907174-FS1-2,This study concluded that the addition of LIDOCAINE significantly reduced the PAIN felt in the circulatory tract selected for the injection of propofol.,PAIN,LIDOCAINE,RO-may_prevent
503729669,7/17/2014 10:32:57,,1325140425,7/17/2014 10:32:50,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,LIDOCAINE treats PAIN,78,42,,81,51,treats,0.989743318610787,907174-FS1-2,This study concluded that the addition of LIDOCAINE significantly reduced the PAIN felt in the circulatory tract selected for the injection of propofol.,PAIN,LIDOCAINE,RO-may_prevent
503729670,7/16/2014 22:30:18,,1324513386,7/16/2014 22:29:44,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,GLIOBLASTOMA MULTIFORME causes MICROVASCULAR PROLIFERATION,33,86,,59,109,causes,0.762000762001143,901556-FS1-4,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729670,7/16/2014 23:00:24,,1324525355,7/16/2014 23:00:02,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,33,86,,59,109,causes,0.762000762001143,901556-FS1-4,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729670,7/16/2014 23:24:55,,1324535503,7/16/2014 23:24:34,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,GLIOBLASTOMA MULTIFORME causes MICROVASCULAR PROLIFERATION,33,86,,59,109,causes,0.762000762001143,901556-FS1-4,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729670,7/16/2014 23:38:09,,1324541209,7/16/2014 23:37:49,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,no_relation,33,86,,59,109,causes,0.762000762001143,901556-FS1-4,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729670,7/17/2014 00:18:05,,1324558014,7/17/2014 00:17:12,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,33,86,,59,109,causes,0.762000762001143,901556-FS1-4,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729670,7/17/2014 00:49:04,,1324583416,7/17/2014 00:48:59,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,MICROVASCULAR PROLIFERATION causes GLIOBLASTOMA MULTIFORME,33,86,,59,109,causes,0.762000762001143,901556-FS1-4,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729670,7/17/2014 02:18:09,,1324670149,7/17/2014 02:17:56,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,GLIOBLASTOMA MULTIFORME causes MICROVASCULAR PROLIFERATION,33,86,,59,109,causes,0.762000762001143,901556-FS1-4,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in GLIOBLASTOMA MULTIFORME it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA MULTIFORME,RO-disease_has_finding
503729671,7/16/2014 22:28:22,,1324512686,7/16/2014 22:28:14,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,BONE METASTASES causes PATHOLOGIC FRACTURES,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/16/2014 22:55:26,,1324523602,7/16/2014 22:54:36,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/16/2014 23:00:47,,1324525442,7/16/2014 23:00:36,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/16/2014 23:46:15,,1324544261,7/16/2014 23:45:06,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,BONE METASTASES causes PATHOLOGIC FRACTURES,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/17/2014 00:09:30,,1324554669,7/17/2014 00:09:01,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,no_relation,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/17/2014 07:05:36,,1324935095,7/17/2014 07:05:27,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729671,7/17/2014 09:30:20,,1325084172,7/17/2014 09:29:32,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,no_relation,48,32,,67,47,causes,0.50709255283711,902836-FS1-4,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729672,7/16/2014 22:24:57,,1324511017,7/16/2014 22:24:29,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,ANAPLASTIC ASTROCYTOMAS treats ANAPLASIA,100,0,,108,23,treats,0.372104203767625,901910-FS1-2,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729672,7/16/2014 22:30:44,,1324513606,7/16/2014 22:30:20,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,ANAPLASIA treats ANAPLASTIC ASTROCYTOMAS,100,0,,108,23,treats,0.372104203767625,901910-FS1-2,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729672,7/16/2014 23:01:00,,1324525499,7/16/2014 23:00:50,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,100,0,,108,23,treats,0.372104203767625,901910-FS1-2,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729672,7/17/2014 01:25:31,,1324617710,7/17/2014 01:24:58,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,ANAPLASTIC ASTROCYTOMAS treats ANAPLASIA,100,0,,108,23,treats,0.372104203767625,901910-FS1-2,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729672,7/17/2014 02:19:51,,1324672009,7/17/2014 02:19:14,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,ANAPLASTIC ASTROCYTOMAS treats ANAPLASIA,100,0,,108,23,treats,0.372104203767625,901910-FS1-2,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729672,7/17/2014 09:31:14,,1325085230,7/17/2014 09:30:54,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,ANAPLASTIC ASTROCYTOMAS treats ANAPLASIA,100,0,,108,23,treats,0.372104203767625,901910-FS1-2,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729672,7/17/2014 10:37:41,,1325144282,7/17/2014 10:37:22,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,ANAPLASTIC ASTROCYTOMAS treats ANAPLASIA,100,0,,108,23,treats,0.372104203767625,901910-FS1-2,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729673,7/16/2014 22:45:06,,1324519371,7/16/2014 22:44:50,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,SCHIZOPHRENIA causes HALLUCINATIONS,65,11,,78,24,causes,0.979957887012223,906248-FS1-4,"1   Simple SCHIZOPHRENIA denotes a milder psychosis (i.e., fewer HALLUCINATIONS and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",HALLUCINATIONS,SCHIZOPHRENIA,RO-has_manifestation
503729673,7/16/2014 22:56:41,,1324524110,7/16/2014 22:56:29,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,SCHIZOPHRENIA causes HALLUCINATIONS,65,11,,78,24,causes,0.979957887012223,906248-FS1-4,"1   Simple SCHIZOPHRENIA denotes a milder psychosis (i.e., fewer HALLUCINATIONS and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",HALLUCINATIONS,SCHIZOPHRENIA,RO-has_manifestation
503729673,7/16/2014 23:14:49,,1324530532,7/16/2014 23:14:25,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,SCHIZOPHRENIA causes HALLUCINATIONS,65,11,,78,24,causes,0.979957887012223,906248-FS1-4,"1   Simple SCHIZOPHRENIA denotes a milder psychosis (i.e., fewer HALLUCINATIONS and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",HALLUCINATIONS,SCHIZOPHRENIA,RO-has_manifestation
503729673,7/17/2014 00:34:39,,1324569628,7/17/2014 00:34:08,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,SCHIZOPHRENIA causes HALLUCINATIONS,65,11,,78,24,causes,0.979957887012223,906248-FS1-4,"1   Simple SCHIZOPHRENIA denotes a milder psychosis (i.e., fewer HALLUCINATIONS and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",HALLUCINATIONS,SCHIZOPHRENIA,RO-has_manifestation
503729673,7/17/2014 01:23:12,,1324615485,7/17/2014 01:22:41,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,HALLUCINATIONS causes SCHIZOPHRENIA,65,11,,78,24,causes,0.979957887012223,906248-FS1-4,"1   Simple SCHIZOPHRENIA denotes a milder psychosis (i.e., fewer HALLUCINATIONS and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",HALLUCINATIONS,SCHIZOPHRENIA,RO-has_manifestation
503729673,7/17/2014 03:09:52,,1324722432,7/17/2014 03:09:29,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,SCHIZOPHRENIA causes HALLUCINATIONS,65,11,,78,24,causes,0.979957887012223,906248-FS1-4,"1   Simple SCHIZOPHRENIA denotes a milder psychosis (i.e., fewer HALLUCINATIONS and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",HALLUCINATIONS,SCHIZOPHRENIA,RO-has_manifestation
503729673,7/17/2014 06:02:26,,1324876939,7/17/2014 06:01:53,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,SCHIZOPHRENIA causes HALLUCINATIONS,65,11,,78,24,causes,0.979957887012223,906248-FS1-4,"1   Simple SCHIZOPHRENIA denotes a milder psychosis (i.e., fewer HALLUCINATIONS and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",HALLUCINATIONS,SCHIZOPHRENIA,RO-has_manifestation
503729674,7/16/2014 22:28:22,,1324512687,7/16/2014 22:28:14,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,142,0,,153,30,causes,0.445435403187374,905340-FS1-4,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729674,7/16/2014 22:52:11,,1324522139,7/16/2014 22:51:51,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,142,0,,153,30,causes,0.445435403187374,905340-FS1-4,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729674,7/16/2014 23:01:26,,1324525644,7/16/2014 23:01:04,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,142,0,,153,30,causes,0.445435403187374,905340-FS1-4,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729674,7/16/2014 23:10:44,,1324528929,7/16/2014 23:09:49,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,UPPER AIRWAY causes OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,causes,0.445435403187374,905340-FS1-4,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729674,7/16/2014 23:36:23,,1324540391,7/16/2014 23:35:44,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,no_relation,142,0,,153,30,causes,0.445435403187374,905340-FS1-4,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729674,7/17/2014 00:26:48,,1324563167,7/17/2014 00:26:22,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,OBSTRUCTIVE SLEEP APNOEA (OSA) causes UPPER AIRWAY,142,0,,153,30,causes,0.445435403187374,905340-FS1-4,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729674,7/17/2014 07:05:15,,1324934728,7/17/2014 07:05:00,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,UPPER AIRWAY causes OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,causes,0.445435403187374,905340-FS1-4,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729675,7/16/2014 22:26:04,,1324511530,7/16/2014 22:25:33,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,VENOUS THROMBOSIS diagnosed by THROMBOSED VEINS,18,104,,33,121,diagnosed by,0.433012701892219,905367-FS1-13,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729675,7/16/2014 22:28:12,,1324512580,7/16/2014 22:27:59,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,18,104,,33,121,diagnosed by,0.433012701892219,905367-FS1-13,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729675,7/16/2014 22:29:37,,1324513151,7/16/2014 22:29:29,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,no_relation,18,104,,33,121,diagnosed by,0.433012701892219,905367-FS1-13,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729675,7/16/2014 23:25:18,,1324535661,7/16/2014 23:24:56,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,THROMBOSED VEINS diagnosed by VENOUS THROMBOSIS,18,104,,33,121,diagnosed by,0.433012701892219,905367-FS1-13,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729675,7/17/2014 00:27:51,,1324564139,7/17/2014 00:27:30,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,VENOUS THROMBOSIS diagnosed by THROMBOSED VEINS,18,104,,33,121,diagnosed by,0.433012701892219,905367-FS1-13,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729675,7/17/2014 10:01:38,,1325114563,7/17/2014 10:01:02,prodege,0.7163,25949006,GBR,"","",62.249.242.67,VENOUS THROMBOSIS diagnosed by THROMBOSED VEINS,18,104,,33,121,diagnosed by,0.433012701892219,905367-FS1-13,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729675,7/17/2014 10:34:31,,1325141785,7/17/2014 10:34:10,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,VENOUS THROMBOSIS diagnosed by THROMBOSED VEINS,18,104,,33,121,diagnosed by,0.433012701892219,905367-FS1-13,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729676,7/16/2014 22:31:09,,1324513771,7/16/2014 22:30:51,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,INTRACTABLE EPILEPSY causes SEIZURES,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/16/2014 22:46:05,,1324519800,7/16/2014 22:45:50,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,INTRACTABLE EPILEPSY causes SEIZURES,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/16/2014 22:52:36,,1324522313,7/16/2014 22:52:12,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,INTRACTABLE EPILEPSY causes SEIZURES,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/16/2014 23:33:36,,1324539073,7/16/2014 23:33:21,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/17/2014 06:40:27,,1324910145,7/17/2014 06:39:56,instagc,0.5978,18634892,USA,"","",68.102.93.185,INTRACTABLE EPILEPSY causes SEIZURES,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/17/2014 09:30:20,,1325084166,7/17/2014 09:29:32,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,no_relation,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/17/2014 10:36:17,,1325143288,7/17/2014 10:36:00,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,SEIZURES causes INTRACTABLE EPILEPSY,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729677,7/16/2014 22:32:00,,1324514087,7/16/2014 22:31:11,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,DERMATOSES OF DIVERSE ETIOLOGIES causes SKIN DISEASES,16,59,,28,91,causes,0.304997140665209,905095-FS1-4,The spectrum of SKIN DISEASES in such patients encompasses DERMATOSES OF DIVERSE ETIOLOGIES; a few are peculiar to patients with HIV while others are not.,SKIN DISEASES,DERMATOSES OF DIVERSE ETIOLOGIES,RO-has_finding_site
503729677,7/16/2014 23:25:40,,1324535808,7/16/2014 23:25:18,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,DERMATOSES OF DIVERSE ETIOLOGIES causes SKIN DISEASES,16,59,,28,91,causes,0.304997140665209,905095-FS1-4,The spectrum of SKIN DISEASES in such patients encompasses DERMATOSES OF DIVERSE ETIOLOGIES; a few are peculiar to patients with HIV while others are not.,SKIN DISEASES,DERMATOSES OF DIVERSE ETIOLOGIES,RO-has_finding_site
503729677,7/17/2014 03:10:16,,1324722765,7/17/2014 03:09:59,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,DERMATOSES OF DIVERSE ETIOLOGIES causes SKIN DISEASES,16,59,,28,91,causes,0.304997140665209,905095-FS1-4,The spectrum of SKIN DISEASES in such patients encompasses DERMATOSES OF DIVERSE ETIOLOGIES; a few are peculiar to patients with HIV while others are not.,SKIN DISEASES,DERMATOSES OF DIVERSE ETIOLOGIES,RO-has_finding_site
503729677,7/17/2014 06:04:36,,1324878634,7/17/2014 06:04:16,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,no_relation,16,59,,28,91,causes,0.304997140665209,905095-FS1-4,The spectrum of SKIN DISEASES in such patients encompasses DERMATOSES OF DIVERSE ETIOLOGIES; a few are peculiar to patients with HIV while others are not.,SKIN DISEASES,DERMATOSES OF DIVERSE ETIOLOGIES,RO-has_finding_site
503729677,7/17/2014 06:12:53,,1324885713,7/17/2014 06:12:37,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,no_relation,16,59,,28,91,causes,0.304997140665209,905095-FS1-4,The spectrum of SKIN DISEASES in such patients encompasses DERMATOSES OF DIVERSE ETIOLOGIES; a few are peculiar to patients with HIV while others are not.,SKIN DISEASES,DERMATOSES OF DIVERSE ETIOLOGIES,RO-has_finding_site
503729677,7/17/2014 06:38:33,,1324908403,7/17/2014 06:38:17,instagc,0.5978,18634892,USA,"","",68.102.93.185,DERMATOSES OF DIVERSE ETIOLOGIES causes SKIN DISEASES,16,59,,28,91,causes,0.304997140665209,905095-FS1-4,The spectrum of SKIN DISEASES in such patients encompasses DERMATOSES OF DIVERSE ETIOLOGIES; a few are peculiar to patients with HIV while others are not.,SKIN DISEASES,DERMATOSES OF DIVERSE ETIOLOGIES,RO-has_finding_site
503729677,7/17/2014 07:44:55,,1324979545,7/17/2014 07:44:41,instagc,0.698,18960682,GBR,"","",86.29.147.112,no_relation,16,59,,28,91,causes,0.304997140665209,905095-FS1-4,The spectrum of SKIN DISEASES in such patients encompasses DERMATOSES OF DIVERSE ETIOLOGIES; a few are peculiar to patients with HIV while others are not.,SKIN DISEASES,DERMATOSES OF DIVERSE ETIOLOGIES,RO-has_finding_site
503729678,7/16/2014 22:51:49,,1324522017,7/16/2014 22:51:31,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,ALLERGY causes HYPERSENSITIVITY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/16/2014 22:51:51,,1324522021,7/16/2014 22:51:19,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,HYPERSENSITIVITY causes ALLERGY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/17/2014 00:10:22,,1324555026,7/17/2014 00:09:56,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,ALLERGY causes HYPERSENSITIVITY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/17/2014 01:26:14,,1324618360,7/17/2014 01:25:37,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,ALLERGY causes HYPERSENSITIVITY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/17/2014 01:38:04,,1324630885,7/17/2014 01:37:38,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,ALLERGY causes HYPERSENSITIVITY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/17/2014 10:02:37,,1325115468,7/17/2014 10:02:19,prodege,0.7163,25949006,GBR,"","",62.249.242.67,ALLERGY causes HYPERSENSITIVITY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/17/2014 10:32:47,,1325140305,7/17/2014 10:32:38,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,HYPERSENSITIVITY causes ALLERGY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729679,7/16/2014 22:50:48,,1324521575,7/16/2014 22:50:14,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,LATE SYSTEMIC ALLERGIC REACTIONS causes NUMBER OF SYSTEMIC ALLERGIC,97,17,,123,49,causes,0.41702882811415,900330-FS1-4,We conclude that LATE SYSTEMIC ALLERGIC REACTIONS account for a significant percent of the total NUMBER OF SYSTEMIC ALLERGIC reactions to inhalant allergen immunotherapy.,NUMBER OF SYSTEMIC ALLERGIC,LATE SYSTEMIC ALLERGIC REACTIONS,RO-cause_of
503729679,7/16/2014 23:31:54,,1324538433,7/16/2014 23:31:15,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,97,17,,123,49,causes,0.41702882811415,900330-FS1-4,We conclude that LATE SYSTEMIC ALLERGIC REACTIONS account for a significant percent of the total NUMBER OF SYSTEMIC ALLERGIC reactions to inhalant allergen immunotherapy.,NUMBER OF SYSTEMIC ALLERGIC,LATE SYSTEMIC ALLERGIC REACTIONS,RO-cause_of
503729679,7/17/2014 02:19:13,,1324671255,7/17/2014 02:18:56,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,NUMBER OF SYSTEMIC ALLERGIC causes LATE SYSTEMIC ALLERGIC REACTIONS,97,17,,123,49,causes,0.41702882811415,900330-FS1-4,We conclude that LATE SYSTEMIC ALLERGIC REACTIONS account for a significant percent of the total NUMBER OF SYSTEMIC ALLERGIC reactions to inhalant allergen immunotherapy.,NUMBER OF SYSTEMIC ALLERGIC,LATE SYSTEMIC ALLERGIC REACTIONS,RO-cause_of
503729679,7/17/2014 06:39:55,,1324909631,7/17/2014 06:39:31,instagc,0.5978,18634892,USA,"","",68.102.93.185,no_relation,97,17,,123,49,causes,0.41702882811415,900330-FS1-4,We conclude that LATE SYSTEMIC ALLERGIC REACTIONS account for a significant percent of the total NUMBER OF SYSTEMIC ALLERGIC reactions to inhalant allergen immunotherapy.,NUMBER OF SYSTEMIC ALLERGIC,LATE SYSTEMIC ALLERGIC REACTIONS,RO-cause_of
503729679,7/17/2014 07:46:06,,1324980807,7/17/2014 07:45:30,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,LATE SYSTEMIC ALLERGIC REACTIONS causes NUMBER OF SYSTEMIC ALLERGIC,97,17,,123,49,causes,0.41702882811415,900330-FS1-4,We conclude that LATE SYSTEMIC ALLERGIC REACTIONS account for a significant percent of the total NUMBER OF SYSTEMIC ALLERGIC reactions to inhalant allergen immunotherapy.,NUMBER OF SYSTEMIC ALLERGIC,LATE SYSTEMIC ALLERGIC REACTIONS,RO-cause_of
503729679,7/17/2014 10:33:35,,1325140978,7/17/2014 10:33:27,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,LATE SYSTEMIC ALLERGIC REACTIONS causes NUMBER OF SYSTEMIC ALLERGIC,97,17,,123,49,causes,0.41702882811415,900330-FS1-4,We conclude that LATE SYSTEMIC ALLERGIC REACTIONS account for a significant percent of the total NUMBER OF SYSTEMIC ALLERGIC reactions to inhalant allergen immunotherapy.,NUMBER OF SYSTEMIC ALLERGIC,LATE SYSTEMIC ALLERGIC REACTIONS,RO-cause_of
503729679,7/17/2014 10:36:09,,1325143177,7/17/2014 10:35:46,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,NUMBER OF SYSTEMIC ALLERGIC causes LATE SYSTEMIC ALLERGIC REACTIONS,97,17,,123,49,causes,0.41702882811415,900330-FS1-4,We conclude that LATE SYSTEMIC ALLERGIC REACTIONS account for a significant percent of the total NUMBER OF SYSTEMIC ALLERGIC reactions to inhalant allergen immunotherapy.,NUMBER OF SYSTEMIC ALLERGIC,LATE SYSTEMIC ALLERGIC REACTIONS,RO-cause_of
503729680,7/16/2014 22:56:41,,1324524111,7/16/2014 22:56:29,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/16/2014 23:24:34,,1324535328,7/16/2014 23:24:12,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/17/2014 01:32:15,,1324624918,7/17/2014 01:32:10,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/17/2014 02:19:51,,1324671994,7/17/2014 02:19:14,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/17/2014 02:36:48,,1324689313,7/17/2014 02:36:21,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/17/2014 06:03:06,,1324877515,7/17/2014 06:02:27,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/17/2014 07:25:17,,1324957577,7/17/2014 07:25:05,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729681,7/16/2014 22:27:40,,1324512300,7/16/2014 22:26:52,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,MALIGNANT MELANOMA diagnosed by MELANOMA PAN,158,60,,169,78,diagnosed by,0.943456353049726,906345-FS1-13,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729681,7/16/2014 22:51:17,,1324521762,7/16/2014 22:50:49,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,MELANOMA PAN diagnosed by MALIGNANT MELANOMA,158,60,,169,78,diagnosed by,0.943456353049726,906345-FS1-13,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729681,7/16/2014 23:15:58,,1324530964,7/16/2014 23:15:26,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,MALIGNANT MELANOMA diagnosed by MELANOMA PAN,158,60,,169,78,diagnosed by,0.943456353049726,906345-FS1-13,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729681,7/17/2014 10:36:17,,1325143267,7/17/2014 10:36:00,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,MALIGNANT MELANOMA diagnosed by MELANOMA PAN,158,60,,169,78,diagnosed by,0.943456353049726,906345-FS1-13,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729681,7/17/2014 10:58:53,,1325160282,7/17/2014 10:58:28,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,MALIGNANT MELANOMA diagnosed by MELANOMA PAN,158,60,,169,78,diagnosed by,0.943456353049726,906345-FS1-13,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729681,7/17/2014 11:11:07,,1325169681,7/17/2014 11:10:44,prodege,0.5714,15439740,AUS,02,Jannali,27.96.208.89,no_relation,158,60,,169,78,diagnosed by,0.943456353049726,906345-FS1-13,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729681,7/17/2014 11:11:28,,1325170012,7/17/2014 11:11:16,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,MELANOMA PAN diagnosed by MALIGNANT MELANOMA,158,60,,169,78,diagnosed by,0.943456353049726,906345-FS1-13,"Microscopic examination of the resected specimen revealed a MALIGNANT MELANOMA which was confirmed by immunohistochemical staining for HMB 45, S 100 protein, MELANOMA PAN and vimentin.",MELANOMA PAN,MALIGNANT MELANOMA,RO-has_manifestation
503729682,7/16/2014 22:24:01,,1324510747,7/16/2014 22:23:23,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.883452208598772,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/16/2014 22:31:09,,1324513756,7/16/2014 22:30:51,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.883452208598772,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/16/2014 22:52:36,,1324522312,7/16/2014 22:52:12,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.883452208598772,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/16/2014 23:36:51,,1324540630,7/16/2014 23:36:25,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.883452208598772,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/16/2014 23:44:20,,1324543537,7/16/2014 23:43:46,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.883452208598772,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/16/2014 23:54:45,,1324547498,7/16/2014 23:54:19,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.883452208598772,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/17/2014 03:11:47,,1324724159,7/17/2014 03:11:26,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.883452208598772,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729683,7/16/2014 22:51:51,,1324522022,7/16/2014 22:51:19,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,BURKHOLDERIA PSEUDOMALLEI causes MELIOIDOSIS,0,85,,24,96,causes,1,903552-FS1-4,BURKHOLDERIA PSEUDOMALLEI is a gram negative bacillus that is the causative agent of MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,RO-has_causative_agent
503729683,7/16/2014 23:08:38,,1324528217,7/16/2014 23:08:02,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,BURKHOLDERIA PSEUDOMALLEI causes MELIOIDOSIS,0,85,,24,96,causes,1,903552-FS1-4,BURKHOLDERIA PSEUDOMALLEI is a gram negative bacillus that is the causative agent of MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,RO-has_causative_agent
503729683,7/16/2014 23:33:36,,1324539074,7/16/2014 23:33:21,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,BURKHOLDERIA PSEUDOMALLEI causes MELIOIDOSIS,0,85,,24,96,causes,1,903552-FS1-4,BURKHOLDERIA PSEUDOMALLEI is a gram negative bacillus that is the causative agent of MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,RO-has_causative_agent
503729683,7/17/2014 00:27:30,,1324563799,7/17/2014 00:27:08,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,BURKHOLDERIA PSEUDOMALLEI causes MELIOIDOSIS,0,85,,24,96,causes,1,903552-FS1-4,BURKHOLDERIA PSEUDOMALLEI is a gram negative bacillus that is the causative agent of MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,RO-has_causative_agent
503729683,7/17/2014 08:48:10,,1325044820,7/17/2014 08:47:48,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,BURKHOLDERIA PSEUDOMALLEI causes MELIOIDOSIS,0,85,,24,96,causes,1,903552-FS1-4,BURKHOLDERIA PSEUDOMALLEI is a gram negative bacillus that is the causative agent of MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,RO-has_causative_agent
503729683,7/17/2014 09:32:24,,1325086652,7/17/2014 09:31:57,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,BURKHOLDERIA PSEUDOMALLEI causes MELIOIDOSIS,0,85,,24,96,causes,1,903552-FS1-4,BURKHOLDERIA PSEUDOMALLEI is a gram negative bacillus that is the causative agent of MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,RO-has_causative_agent
503729683,7/17/2014 10:01:38,,1325114562,7/17/2014 10:01:02,prodege,0.7163,25949006,GBR,"","",62.249.242.67,BURKHOLDERIA PSEUDOMALLEI causes MELIOIDOSIS,0,85,,24,96,causes,1,903552-FS1-4,BURKHOLDERIA PSEUDOMALLEI is a gram negative bacillus that is the causative agent of MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,RO-has_causative_agent
503729684,7/16/2014 23:37:46,,1324541081,7/16/2014 23:37:26,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,SEIZURE causes EPILEPSY,142,180,,148,188,causes,0.888888888888889,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 00:47:36,,1324582169,7/17/2014 00:46:51,instagc,0.4167,19745059,CAN,ON,Saint Catharines,216.121.166.67,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.888888888888889,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 02:18:55,,1324671045,7/17/2014 02:18:25,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.888888888888889,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 03:05:32,,1324718124,7/17/2014 03:05:04,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.888888888888889,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 06:11:24,,1324884580,7/17/2014 06:11:00,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.888888888888889,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 07:27:14,,1324959937,7/17/2014 07:27:00,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.888888888888889,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729684,7/17/2014 07:56:06,,1324991471,7/17/2014 07:55:30,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,EPILEPSY causes SEIZURE,142,180,,148,188,causes,0.888888888888889,904923-FS1-4,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting SEIZURE prognosis was the severity of EPILEPSY prepregnancy.,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
503729685,7/16/2014 22:30:44,,1324513605,7/16/2014 22:30:20,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,no_relation,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/16/2014 23:15:25,,1324530732,7/16/2014 23:14:51,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,ANAPLASTIC ASTROCYTOMAS causes ANAPLASIA,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/16/2014 23:44:21,,1324543547,7/16/2014 23:43:32,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,ANAPLASIA causes ANAPLASTIC ASTROCYTOMAS,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/17/2014 06:40:27,,1324910146,7/17/2014 06:39:56,instagc,0.5978,18634892,USA,"","",68.102.93.185,no_relation,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/17/2014 07:46:06,,1324980806,7/17/2014 07:45:30,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,no_relation,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/17/2014 07:57:01,,1324992309,7/17/2014 07:56:08,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,ANAPLASIA causes ANAPLASTIC ASTROCYTOMAS,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729685,7/17/2014 08:48:30,,1325045134,7/17/2014 08:48:11,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,ANAPLASTIC ASTROCYTOMAS causes ANAPLASIA,100,0,,108,23,causes,0.620173672946042,901910-FS1-4,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed progressive reduction of parenchymal positivity as ANAPLASIA increased.,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,RO-disease_has_finding
503729686,7/16/2014 23:54:59,,1324547591,7/16/2014 23:54:46,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,HYPERTENSION causes ACUTE HYPERTENSIVE ENCEPHALOPATHY,46,103,,57,136,causes,0.993127066322841,901623-FS1-4,Headache may occasionally be caused by severe HYPERTENSION which may also lead to the rare syndrome of ACUTE HYPERTENSIVE ENCEPHALOPATHY,HYPERTENSION,ACUTE HYPERTENSIVE ENCEPHALOPATHY,RO-disease_has_finding
503729686,7/17/2014 07:45:06,,1324979736,7/17/2014 07:44:55,instagc,0.698,18960682,GBR,"","",86.29.147.112,HYPERTENSION causes ACUTE HYPERTENSIVE ENCEPHALOPATHY,46,103,,57,136,causes,0.993127066322841,901623-FS1-4,Headache may occasionally be caused by severe HYPERTENSION which may also lead to the rare syndrome of ACUTE HYPERTENSIVE ENCEPHALOPATHY,HYPERTENSION,ACUTE HYPERTENSIVE ENCEPHALOPATHY,RO-disease_has_finding
503729686,7/17/2014 10:02:18,,1325115213,7/17/2014 10:01:39,prodege,0.7163,25949006,GBR,"","",62.249.242.67,no_relation,46,103,,57,136,causes,0.993127066322841,901623-FS1-4,Headache may occasionally be caused by severe HYPERTENSION which may also lead to the rare syndrome of ACUTE HYPERTENSIVE ENCEPHALOPATHY,HYPERTENSION,ACUTE HYPERTENSIVE ENCEPHALOPATHY,RO-disease_has_finding
503729686,7/17/2014 10:35:59,,1325143097,7/17/2014 10:35:41,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,HYPERTENSION causes ACUTE HYPERTENSIVE ENCEPHALOPATHY,46,103,,57,136,causes,0.993127066322841,901623-FS1-4,Headache may occasionally be caused by severe HYPERTENSION which may also lead to the rare syndrome of ACUTE HYPERTENSIVE ENCEPHALOPATHY,HYPERTENSION,ACUTE HYPERTENSIVE ENCEPHALOPATHY,RO-disease_has_finding
503729686,7/17/2014 10:38:25,,1325144837,7/17/2014 10:38:14,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,HYPERTENSION causes ACUTE HYPERTENSIVE ENCEPHALOPATHY,46,103,,57,136,causes,0.993127066322841,901623-FS1-4,Headache may occasionally be caused by severe HYPERTENSION which may also lead to the rare syndrome of ACUTE HYPERTENSIVE ENCEPHALOPATHY,HYPERTENSION,ACUTE HYPERTENSIVE ENCEPHALOPATHY,RO-disease_has_finding
503729686,7/17/2014 10:58:53,,1325160283,7/17/2014 10:58:28,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,HYPERTENSION causes ACUTE HYPERTENSIVE ENCEPHALOPATHY,46,103,,57,136,causes,0.993127066322841,901623-FS1-4,Headache may occasionally be caused by severe HYPERTENSION which may also lead to the rare syndrome of ACUTE HYPERTENSIVE ENCEPHALOPATHY,HYPERTENSION,ACUTE HYPERTENSIVE ENCEPHALOPATHY,RO-disease_has_finding
503729686,7/17/2014 11:11:37,,1325170170,7/17/2014 11:11:10,prodege,0.5714,15439740,AUS,02,Jannali,27.96.208.89,ACUTE HYPERTENSIVE ENCEPHALOPATHY causes HYPERTENSION,46,103,,57,136,causes,0.993127066322841,901623-FS1-4,Headache may occasionally be caused by severe HYPERTENSION which may also lead to the rare syndrome of ACUTE HYPERTENSIVE ENCEPHALOPATHY,HYPERTENSION,ACUTE HYPERTENSIVE ENCEPHALOPATHY,RO-disease_has_finding
503729687,7/16/2014 22:56:27,,1324524026,7/16/2014 22:56:02,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,ALLERGIC REACTIONS causes ALLERGIC DISORDERS,289,328,,306,346,causes,0.949425326555083,900233-FS1-4,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to ALLERGIC DISORDERS or may be caused by ALLERGIC REACTIONS",ALLERGIC DISORDERS,ALLERGIC REACTIONS,RO-cause_of
503729687,7/17/2014 01:24:51,,1324617115,7/17/2014 01:24:17,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,ALLERGIC REACTIONS causes ALLERGIC DISORDERS,289,328,,306,346,causes,0.949425326555083,900233-FS1-4,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to ALLERGIC DISORDERS or may be caused by ALLERGIC REACTIONS",ALLERGIC DISORDERS,ALLERGIC REACTIONS,RO-cause_of
503729687,7/17/2014 01:32:32,,1324625143,7/17/2014 01:32:24,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,ALLERGIC DISORDERS causes ALLERGIC REACTIONS,289,328,,306,346,causes,0.949425326555083,900233-FS1-4,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to ALLERGIC DISORDERS or may be caused by ALLERGIC REACTIONS",ALLERGIC DISORDERS,ALLERGIC REACTIONS,RO-cause_of
503729687,7/17/2014 03:09:28,,1324722069,7/17/2014 03:09:00,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,289,328,,306,346,causes,0.949425326555083,900233-FS1-4,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to ALLERGIC DISORDERS or may be caused by ALLERGIC REACTIONS",ALLERGIC DISORDERS,ALLERGIC REACTIONS,RO-cause_of
503729687,7/17/2014 06:39:30,,1324909280,7/17/2014 06:39:06,instagc,0.5978,18634892,USA,"","",68.102.93.185,no_relation,289,328,,306,346,causes,0.949425326555083,900233-FS1-4,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to ALLERGIC DISORDERS or may be caused by ALLERGIC REACTIONS",ALLERGIC DISORDERS,ALLERGIC REACTIONS,RO-cause_of
503729687,7/17/2014 07:48:15,,1324983136,7/17/2014 07:47:28,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,no_relation,289,328,,306,346,causes,0.949425326555083,900233-FS1-4,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to ALLERGIC DISORDERS or may be caused by ALLERGIC REACTIONS",ALLERGIC DISORDERS,ALLERGIC REACTIONS,RO-cause_of
503729687,7/17/2014 08:48:50,,1325045359,7/17/2014 08:48:31,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,ALLERGIC DISORDERS causes ALLERGIC REACTIONS,289,328,,306,346,causes,0.949425326555083,900233-FS1-4,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to ALLERGIC DISORDERS or may be caused by ALLERGIC REACTIONS",ALLERGIC DISORDERS,ALLERGIC REACTIONS,RO-cause_of
503729688,7/16/2014 23:16:53,,1324531352,7/16/2014 23:15:59,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,28,0,,51,4,causes,0.971285862357264,902982-FS1-4,SMZL is characterized by an INDOLENT CLINICAL COURSE and no previous report has described SMZL with bilateral renal invasion.,INDOLENT CLINICAL COURSE,SMZL,RO-disease_may_have_finding
503729688,7/16/2014 23:26:34,,1324536176,7/16/2014 23:26:16,instagc,0.7639,13763729,USA,"","",75.182.89.225,no_relation,28,0,,51,4,causes,0.971285862357264,902982-FS1-4,SMZL is characterized by an INDOLENT CLINICAL COURSE and no previous report has described SMZL with bilateral renal invasion.,INDOLENT CLINICAL COURSE,SMZL,RO-disease_may_have_finding
503729688,7/16/2014 23:44:21,,1324543552,7/16/2014 23:43:32,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,SMZL causes INDOLENT CLINICAL COURSE,28,0,,51,4,causes,0.971285862357264,902982-FS1-4,SMZL is characterized by an INDOLENT CLINICAL COURSE and no previous report has described SMZL with bilateral renal invasion.,INDOLENT CLINICAL COURSE,SMZL,RO-disease_may_have_finding
503729688,7/17/2014 01:25:31,,1324617715,7/17/2014 01:24:58,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,INDOLENT CLINICAL COURSE causes SMZL,28,0,,51,4,causes,0.971285862357264,902982-FS1-4,SMZL is characterized by an INDOLENT CLINICAL COURSE and no previous report has described SMZL with bilateral renal invasion.,INDOLENT CLINICAL COURSE,SMZL,RO-disease_may_have_finding
503729688,7/17/2014 02:18:24,,1324670446,7/17/2014 02:18:09,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,INDOLENT CLINICAL COURSE causes SMZL,28,0,,51,4,causes,0.971285862357264,902982-FS1-4,SMZL is characterized by an INDOLENT CLINICAL COURSE and no previous report has described SMZL with bilateral renal invasion.,INDOLENT CLINICAL COURSE,SMZL,RO-disease_may_have_finding
503729688,7/17/2014 02:36:48,,1324689300,7/17/2014 02:36:21,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,28,0,,51,4,causes,0.971285862357264,902982-FS1-4,SMZL is characterized by an INDOLENT CLINICAL COURSE and no previous report has described SMZL with bilateral renal invasion.,INDOLENT CLINICAL COURSE,SMZL,RO-disease_may_have_finding
503729688,7/17/2014 03:10:16,,1324722763,7/17/2014 03:09:59,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,INDOLENT CLINICAL COURSE causes SMZL,28,0,,51,4,causes,0.971285862357264,902982-FS1-4,SMZL is characterized by an INDOLENT CLINICAL COURSE and no previous report has described SMZL with bilateral renal invasion.,INDOLENT CLINICAL COURSE,SMZL,RO-disease_may_have_finding
503729689,7/16/2014 22:52:58,,1324522441,7/16/2014 22:52:38,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,175,242,,186,261,is location of,0.304997140665209,902601-FS1-9,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729689,7/16/2014 23:54:18,,1324547337,7/16/2014 23:53:47,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,no_relation,175,242,,186,261,is location of,0.304997140665209,902601-FS1-9,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729689,7/17/2014 03:40:40,,1324752293,7/17/2014 03:39:55,instagc,0.7319,20183814,USA,"","",166.182.81.199,no_relation,175,242,,186,261,is location of,0.304997140665209,902601-FS1-9,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729689,7/17/2014 04:56:25,,1324820836,7/17/2014 04:55:39,prodege,0.7105,27934334,GBR,"","",86.130.153.15,no_relation,175,242,,186,261,is location of,0.304997140665209,902601-FS1-9,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729689,7/17/2014 06:05:27,,1324879278,7/17/2014 06:04:59,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,COLD NODULES is location of MEDULLARY CARCINOMA,175,242,,186,261,is location of,0.304997140665209,902601-FS1-9,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729689,7/17/2014 07:26:59,,1324959676,7/17/2014 07:25:51,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,no_relation,175,242,,186,261,is location of,0.304997140665209,902601-FS1-9,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729689,7/17/2014 07:44:11,,1324978685,7/17/2014 07:43:55,instagc,0.698,18960682,GBR,"","",86.29.147.112,no_relation,175,242,,186,261,is location of,0.304997140665209,902601-FS1-9,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729690,7/16/2014 22:33:57,,1324514808,7/16/2014 22:33:19,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY causes ADRENALINE INDUCED ARRHYTHMIA,162,122,,190,158,causes,0.400891862868637,907226-FS1-4,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729690,7/16/2014 23:24:34,,1324535331,7/16/2014 23:24:12,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,ADRENALINE INDUCED ARRHYTHMIA causes PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,162,122,,190,158,causes,0.400891862868637,907226-FS1-4,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729690,7/16/2014 23:33:02,,1324538898,7/16/2014 23:32:22,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,162,122,,190,158,causes,0.400891862868637,907226-FS1-4,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729690,7/17/2014 00:33:39,,1324568921,7/17/2014 00:32:55,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,162,122,,190,158,causes,0.400891862868637,907226-FS1-4,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729690,7/17/2014 07:45:29,,1324980188,7/17/2014 07:44:43,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY causes ADRENALINE INDUCED ARRHYTHMIA,162,122,,190,158,causes,0.400891862868637,907226-FS1-4,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729690,7/17/2014 10:33:16,,1325140708,7/17/2014 10:33:10,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,162,122,,190,158,causes,0.400891862868637,907226-FS1-4,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729690,7/17/2014 10:33:55,,1325141286,7/17/2014 10:33:30,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,ADRENALINE INDUCED ARRHYTHMIA causes PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,162,122,,190,158,causes,0.400891862868637,907226-FS1-4,"Among the compounds tested, 1 (2 hydroxy 3 (4 phenylpiperidin 1 yl) propylpyrrolidin 2 one (5) was the most active in the PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY in ADRENALINE INDUCED ARRHYTHMIA in anesthetized rats.",ADRENALINE INDUCED ARRHYTHMIA,PROPHYLACTIC ANTIARRHYTHMIC ACTIVITY,RO-may_prevent
503729691,7/16/2014 22:36:21,,1324516066,7/16/2014 22:36:02,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,TREPONEMA PALLIDUM diagnosed by SYPHILIS,76,133,,93,141,diagnosed by,0.923760430703401,903820-FS1-13,The CAPTIA Syphilis G enzyme immunoassay for the detection of antibodies to TREPONEMA PALLIDUM was evaluated as a screening test for SYPHILIS in comparison with the standard rapid plasma reagin (RPR) test.,TREPONEMA PALLIDUM,SYPHILIS,RO-has_causative_agent
503729691,7/17/2014 00:49:16,,1324583634,7/17/2014 00:49:11,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,SYPHILIS diagnosed by TREPONEMA PALLIDUM,76,133,,93,141,diagnosed by,0.923760430703401,903820-FS1-13,The CAPTIA Syphilis G enzyme immunoassay for the detection of antibodies to TREPONEMA PALLIDUM was evaluated as a screening test for SYPHILIS in comparison with the standard rapid plasma reagin (RPR) test.,TREPONEMA PALLIDUM,SYPHILIS,RO-has_causative_agent
503729691,7/17/2014 03:09:00,,1324721660,7/17/2014 03:08:33,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,SYPHILIS diagnosed by TREPONEMA PALLIDUM,76,133,,93,141,diagnosed by,0.923760430703401,903820-FS1-13,The CAPTIA Syphilis G enzyme immunoassay for the detection of antibodies to TREPONEMA PALLIDUM was evaluated as a screening test for SYPHILIS in comparison with the standard rapid plasma reagin (RPR) test.,TREPONEMA PALLIDUM,SYPHILIS,RO-has_causative_agent
503729691,7/17/2014 07:05:15,,1324934726,7/17/2014 07:05:00,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,SYPHILIS diagnosed by TREPONEMA PALLIDUM,76,133,,93,141,diagnosed by,0.923760430703401,903820-FS1-13,The CAPTIA Syphilis G enzyme immunoassay for the detection of antibodies to TREPONEMA PALLIDUM was evaluated as a screening test for SYPHILIS in comparison with the standard rapid plasma reagin (RPR) test.,TREPONEMA PALLIDUM,SYPHILIS,RO-has_causative_agent
503729691,7/17/2014 07:44:28,,1324979039,7/17/2014 07:44:11,instagc,0.698,18960682,GBR,"","",86.29.147.112,SYPHILIS diagnosed by TREPONEMA PALLIDUM,76,133,,93,141,diagnosed by,0.923760430703401,903820-FS1-13,The CAPTIA Syphilis G enzyme immunoassay for the detection of antibodies to TREPONEMA PALLIDUM was evaluated as a screening test for SYPHILIS in comparison with the standard rapid plasma reagin (RPR) test.,TREPONEMA PALLIDUM,SYPHILIS,RO-has_causative_agent
503729691,7/17/2014 08:49:09,,1325045642,7/17/2014 08:48:51,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,TREPONEMA PALLIDUM diagnosed by SYPHILIS,76,133,,93,141,diagnosed by,0.923760430703401,903820-FS1-13,The CAPTIA Syphilis G enzyme immunoassay for the detection of antibodies to TREPONEMA PALLIDUM was evaluated as a screening test for SYPHILIS in comparison with the standard rapid plasma reagin (RPR) test.,TREPONEMA PALLIDUM,SYPHILIS,RO-has_causative_agent
503729691,7/17/2014 10:34:09,,1325141473,7/17/2014 10:33:55,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,SYPHILIS diagnosed by TREPONEMA PALLIDUM,76,133,,93,141,diagnosed by,0.923760430703401,903820-FS1-13,The CAPTIA Syphilis G enzyme immunoassay for the detection of antibodies to TREPONEMA PALLIDUM was evaluated as a screening test for SYPHILIS in comparison with the standard rapid plasma reagin (RPR) test.,TREPONEMA PALLIDUM,SYPHILIS,RO-has_causative_agent
503729692,7/16/2014 23:15:25,,1324530734,7/16/2014 23:14:51,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/16/2014 23:26:34,,1324536175,7/16/2014 23:26:16,instagc,0.7639,13763729,USA,"","",75.182.89.225,no_relation,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/16/2014 23:35:42,,1324540058,7/16/2014 23:35:10,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,no_relation,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/16/2014 23:43:14,,1324543170,7/16/2014 23:43:05,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,ENTERIC FEVER diagnosed by INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/17/2014 01:24:12,,1324616470,7/17/2014 01:23:29,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS diagnosed by ENTERIC FEVER,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/17/2014 07:30:38,,1324963865,7/17/2014 07:30:04,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729692,7/17/2014 08:49:09,,1325045643,7/17/2014 08:48:51,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,no_relation,82,105,,94,149,diagnosed by,0.304997140665209,901702-FS1-13,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes ENTERIC FEVER malaria, INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala azar.",ENTERIC FEVER,INFECTIOUS MONONUCLEOSIS (EPSTEIN BARR VIRUS,RO-disease_has_finding
503729693,7/16/2014 22:24:28,,1324510857,7/16/2014 22:24:02,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,LUNGS is location of LUNG CANCER,46,59,,50,70,is location of,0.981980506061966,902200-FS1-9,The distribution of ferruginous bodies in the LUNGS of ten LUNG CANCER patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,LUNGS,LUNG CANCER,RO-disease_has_primary_anatomic_site
503729693,7/16/2014 22:30:18,,1324513391,7/16/2014 22:29:44,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,LUNGS is location of LUNG CANCER,46,59,,50,70,is location of,0.981980506061966,902200-FS1-9,The distribution of ferruginous bodies in the LUNGS of ten LUNG CANCER patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,LUNGS,LUNG CANCER,RO-disease_has_primary_anatomic_site
503729693,7/16/2014 22:52:11,,1324522136,7/16/2014 22:51:51,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,LUNGS is location of LUNG CANCER,46,59,,50,70,is location of,0.981980506061966,902200-FS1-9,The distribution of ferruginous bodies in the LUNGS of ten LUNG CANCER patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,LUNGS,LUNG CANCER,RO-disease_has_primary_anatomic_site
503729693,7/17/2014 00:09:55,,1324554837,7/17/2014 00:09:31,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,LUNGS is location of LUNG CANCER,46,59,,50,70,is location of,0.981980506061966,902200-FS1-9,The distribution of ferruginous bodies in the LUNGS of ten LUNG CANCER patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,LUNGS,LUNG CANCER,RO-disease_has_primary_anatomic_site
503729693,7/17/2014 04:45:12,,1324811102,7/17/2014 04:44:59,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,LUNGS is location of LUNG CANCER,46,59,,50,70,is location of,0.981980506061966,902200-FS1-9,The distribution of ferruginous bodies in the LUNGS of ten LUNG CANCER patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,LUNGS,LUNG CANCER,RO-disease_has_primary_anatomic_site
503729693,7/17/2014 04:57:56,,1324822326,7/17/2014 04:57:32,prodege,0.7105,27934334,GBR,"","",86.130.153.15,LUNGS is location of LUNG CANCER,46,59,,50,70,is location of,0.981980506061966,902200-FS1-9,The distribution of ferruginous bodies in the LUNGS of ten LUNG CANCER patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,LUNGS,LUNG CANCER,RO-disease_has_primary_anatomic_site
503729693,7/17/2014 07:29:45,,1324962729,7/17/2014 07:29:16,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,LUNGS is location of LUNG CANCER,46,59,,50,70,is location of,0.981980506061966,902200-FS1-9,The distribution of ferruginous bodies in the LUNGS of ten LUNG CANCER patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,LUNGS,LUNG CANCER,RO-disease_has_primary_anatomic_site
503729694,7/16/2014 22:24:48,,1324510967,7/16/2014 22:24:38,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,SERTRALINE treats DEPRESSION,137,14,,146,24,treats,0.929981109950554,907692-FS1-2,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
503729694,7/16/2014 22:28:51,,1324512847,7/16/2014 22:28:37,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,137,14,,146,24,treats,0.929981109950554,907692-FS1-2,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
503729694,7/16/2014 23:07:36,,1324527837,7/16/2014 23:06:47,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,SERTRALINE treats DEPRESSION,137,14,,146,24,treats,0.929981109950554,907692-FS1-2,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
503729694,7/17/2014 00:19:08,,1324558593,7/17/2014 00:18:50,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,137,14,,146,24,treats,0.929981109950554,907692-FS1-2,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
503729694,7/17/2014 00:32:53,,1324568260,7/17/2014 00:32:24,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,SERTRALINE treats DEPRESSION,137,14,,146,24,treats,0.929981109950554,907692-FS1-2,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
503729694,7/17/2014 00:48:49,,1324583211,7/17/2014 00:48:44,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,SERTRALINE treats DEPRESSION,137,14,,146,24,treats,0.929981109950554,907692-FS1-2,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
503729694,7/17/2014 01:37:35,,1324630360,7/17/2014 01:37:08,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,SERTRALINE treats DEPRESSION,137,14,,146,24,treats,0.929981109950554,907692-FS1-2,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
503729695,7/16/2014 22:45:48,,1324519639,7/16/2014 22:45:30,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,RESPIRATORY DISTRESS causes WET LUNG,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/16/2014 23:45:05,,1324543796,7/16/2014 23:44:22,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,WET LUNG causes RESPIRATORY DISTRESS,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/17/2014 02:19:13,,1324671249,7/17/2014 02:18:56,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,WET LUNG causes RESPIRATORY DISTRESS,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/17/2014 07:05:26,,1324934927,7/17/2014 07:05:16,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,WET LUNG causes RESPIRATORY DISTRESS,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/17/2014 07:54:55,,1324990157,7/17/2014 07:54:04,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/17/2014 09:29:31,,1325083093,7/17/2014 09:28:15,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,no_relation,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729695,7/17/2014 10:34:51,,1325142036,7/17/2014 10:34:32,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,WET LUNG causes RESPIRATORY DISTRESS,68,91,,87,99,causes,0.845154254728516,901567-FS1-4,Tracheobronchial saline lavage to dislodge meconium may precipitate RESPIRATORY DISTRESS a WET LUNG appearance and respiratory failure.,RESPIRATORY DISTRESS,WET LUNG,RO-disease_has_finding
503729696,7/16/2014 23:26:15,,1324536048,7/16/2014 23:25:51,instagc,0.7639,13763729,USA,"","",75.182.89.225,ASPIRIN treats MI,84,44,,85,51,treats,0.968495996958186,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 10:35:40,,1325142876,7/17/2014 10:35:26,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,ASPIRIN treats MI,84,44,,85,51,treats,0.968495996958186,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 10:36:59,,1325143919,7/17/2014 10:36:29,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,ASPIRIN treats MI,84,44,,85,51,treats,0.968495996958186,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 10:58:26,,1325159961,7/17/2014 10:58:04,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,ASPIRIN treats MI,84,44,,85,51,treats,0.968495996958186,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 11:11:28,,1325170014,7/17/2014 11:11:16,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,ASPIRIN treats MI,84,44,,85,51,treats,0.968495996958186,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 11:12:01,,1325170567,7/17/2014 11:11:39,prodege,0.5714,15439740,AUS,02,Jannali,27.96.208.89,ASPIRIN treats MI,84,44,,85,51,treats,0.968495996958186,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729696,7/17/2014 11:14:02,,1325172265,7/17/2014 11:13:51,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,ASPIRIN treats MI,84,44,,85,51,treats,0.968495996958186,907404-FS1-2,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
503729697,7/16/2014 22:49:09,,1324520921,7/16/2014 22:48:49,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,PATHOLOGIC FRACTURES is location of BONE METASTASES,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 00:32:24,,1324567744,7/17/2014 00:31:47,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,BONE METASTASES is location of PATHOLOGIC FRACTURES,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 04:43:48,,1324809689,7/17/2014 04:43:18,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,no_relation,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 06:03:46,,1324878046,7/17/2014 06:03:06,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,PATHOLOGIC FRACTURES is location of BONE METASTASES,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 07:04:37,,1324934072,7/17/2014 07:04:21,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 07:25:49,,1324958274,7/17/2014 07:25:18,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,BONE METASTASES is location of PATHOLOGIC FRACTURES,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 07:49:01,,1324984094,7/17/2014 07:48:15,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,BONE METASTASES is location of PATHOLOGIC FRACTURES,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729698,7/16/2014 22:29:37,,1324513152,7/16/2014 22:29:29,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,no_relation,183,157,,200,161,diagnosed by,0.372104203767625,902662-FS1-13,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between MICROCALCIFICATION on previous films and high grade invasive ductal carcinomas (P=0.015.",MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
503729698,7/16/2014 23:43:44,,1324543349,7/16/2014 23:43:33,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,MICROCALCIFICATION diagnosed by DCIS,183,157,,200,161,diagnosed by,0.372104203767625,902662-FS1-13,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between MICROCALCIFICATION on previous films and high grade invasive ductal carcinomas (P=0.015.",MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
503729698,7/17/2014 00:28:40,,1324564845,7/17/2014 00:28:12,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,no_relation,183,157,,200,161,diagnosed by,0.372104203767625,902662-FS1-13,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between MICROCALCIFICATION on previous films and high grade invasive ductal carcinomas (P=0.015.",MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
503729698,7/17/2014 01:26:55,,1324619123,7/17/2014 01:26:21,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,MICROCALCIFICATION diagnosed by DCIS,183,157,,200,161,diagnosed by,0.372104203767625,902662-FS1-13,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between MICROCALCIFICATION on previous films and high grade invasive ductal carcinomas (P=0.015.",MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
503729698,7/17/2014 01:32:45,,1324625403,7/17/2014 01:32:39,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,MICROCALCIFICATION diagnosed by DCIS,183,157,,200,161,diagnosed by,0.372104203767625,902662-FS1-13,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between MICROCALCIFICATION on previous films and high grade invasive ductal carcinomas (P=0.015.",MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
503729698,7/17/2014 04:44:14,,1324810053,7/17/2014 04:43:49,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,DCIS diagnosed by MICROCALCIFICATION,183,157,,200,161,diagnosed by,0.372104203767625,902662-FS1-13,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between MICROCALCIFICATION on previous films and high grade invasive ductal carcinomas (P=0.015.",MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
503729698,7/17/2014 06:04:30,,1324878545,7/17/2014 06:03:48,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,MICROCALCIFICATION diagnosed by DCIS,183,157,,200,161,diagnosed by,0.372104203767625,902662-FS1-13,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between MICROCALCIFICATION on previous films and high grade invasive ductal carcinomas (P=0.015.",MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
503729699,7/16/2014 22:27:59,,1324512479,7/16/2014 22:27:41,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,VIRUSES causes VIRAL INFECTION,124,143,,130,158,causes,0.936329177569044,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/16/2014 22:53:47,,1324522853,7/16/2014 22:53:22,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,VIRUSES causes VIRAL INFECTION,124,143,,130,158,causes,0.936329177569044,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/16/2014 23:10:23,,1324528795,7/16/2014 23:09:57,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,124,143,,130,158,causes,0.936329177569044,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/16/2014 23:33:53,,1324539213,7/16/2014 23:33:37,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,124,143,,130,158,causes,0.936329177569044,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/16/2014 23:45:05,,1324543798,7/16/2014 23:44:22,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,VIRUSES causes VIRAL INFECTION,124,143,,130,158,causes,0.936329177569044,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/17/2014 03:10:36,,1324723070,7/17/2014 03:10:21,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,no_relation,124,143,,130,158,causes,0.936329177569044,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729699,7/17/2014 06:39:55,,1324909660,7/17/2014 06:39:31,instagc,0.5978,18634892,USA,"","",68.102.93.185,VIRUSES causes VIRAL INFECTION,124,143,,130,158,causes,0.936329177569044,903536-FS1-4,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or VIRUSES during the VIRAL INFECTION cycle.",VIRUSES,VIRAL INFECTION,RO-has_causative_agent
503729700,7/16/2014 22:24:48,,1324510968,7/16/2014 22:24:38,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,SKIN is location of DERMATOPHYTOSES,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/16/2014 23:10:44,,1324528932,7/16/2014 23:09:49,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,SKIN is location of DERMATOPHYTOSES,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/16/2014 23:37:46,,1324541085,7/16/2014 23:37:26,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,SKIN is location of DERMATOPHYTOSES,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/17/2014 00:34:39,,1324569624,7/17/2014 00:34:08,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,SKIN is location of DERMATOPHYTOSES,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/17/2014 02:18:55,,1324671034,7/17/2014 02:18:25,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,DERMATOPHYTOSES is location of SKIN,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/17/2014 06:02:26,,1324876938,7/17/2014 06:01:53,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,DERMATOPHYTOSES is location of SKIN,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729700,7/17/2014 06:12:36,,1324885491,7/17/2014 06:12:19,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,SKIN is location of DERMATOPHYTOSES,56,112,,59,127,is location of,0.981980506061966,902135-FS1-9,"Between 1994 and 1998, a total of 790 feather, hair and SKIN specimens from a variety of animals with suspected DERMATOPHYTOSES were studied, of which 248 (31.4%) yielded dermatophytes.",SKIN,DERMATOPHYTOSES,RO-disease_has_primary_anatomic_site
503729701,7/16/2014 22:26:01,,1324511487,7/16/2014 22:25:48,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/16/2014 22:27:59,,1324512480,7/16/2014 22:27:41,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/16/2014 23:01:26,,1324525647,7/16/2014 23:01:04,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/16/2014 23:25:01,,1324535536,7/16/2014 23:24:47,instagc,0.7639,13763729,USA,"","",75.182.89.225,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/16/2014 23:31:54,,1324538432,7/16/2014 23:31:15,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/16/2014 23:54:45,,1324547497,7/16/2014 23:54:19,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/17/2014 04:43:48,,1324809691,7/17/2014 04:43:18,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,STAPHYLOCOCCI treats STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729702,7/16/2014 22:26:01,,1324511485,7/16/2014 22:25:48,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299-FS1-2,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
503729702,7/16/2014 22:27:40,,1324512301,7/16/2014 22:26:52,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299-FS1-2,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
503729702,7/16/2014 22:27:58,,1324512441,7/16/2014 22:27:45,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299-FS1-2,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
503729702,7/16/2014 22:29:06,,1324512929,7/16/2014 22:28:43,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299-FS1-2,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
503729702,7/16/2014 22:29:13,,1324512976,7/16/2014 22:29:02,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299-FS1-2,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
503729702,7/16/2014 22:53:20,,1324522612,7/16/2014 22:53:00,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299-FS1-2,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
503729702,7/16/2014 23:00:35,,1324525382,7/16/2014 23:00:25,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299-FS1-2,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
503729703,7/17/2014 00:18:05,,1324558016,7/17/2014 00:17:12,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 01:13:20,,1324606272,7/17/2014 01:12:52,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 02:17:55,,1324669961,7/17/2014 02:17:41,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 03:09:57,,1324722460,7/17/2014 03:09:12,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 03:11:25,,1324723753,7/17/2014 03:10:46,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 03:41:44,,1324753171,7/17/2014 03:41:30,instagc,0.7319,20183814,USA,"","",166.182.81.199,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 06:04:58,,1324878978,7/17/2014 06:04:37,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729704,7/16/2014 22:25:08,,1324511109,7/16/2014 22:24:50,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) causes DYSTONIA,127,18,,134,68,causes,0.936329177569044,906024-FS1-4,"A case of Leigh's DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) is reported with such noteworthy features as early onset, DYSTONIA paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",DYSTONIA,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),RO-has_manifestation
503729704,7/16/2014 22:28:12,,1324512581,7/16/2014 22:27:59,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) causes DYSTONIA,127,18,,134,68,causes,0.936329177569044,906024-FS1-4,"A case of Leigh's DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) is reported with such noteworthy features as early onset, DYSTONIA paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",DYSTONIA,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),RO-has_manifestation
503729704,7/16/2014 23:43:33,,1324543269,7/16/2014 23:43:15,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,DYSTONIA causes DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),127,18,,134,68,causes,0.936329177569044,906024-FS1-4,"A case of Leigh's DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) is reported with such noteworthy features as early onset, DYSTONIA paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",DYSTONIA,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),RO-has_manifestation
503729704,7/16/2014 23:46:15,,1324544260,7/16/2014 23:45:06,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) causes DYSTONIA,127,18,,134,68,causes,0.936329177569044,906024-FS1-4,"A case of Leigh's DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) is reported with such noteworthy features as early onset, DYSTONIA paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",DYSTONIA,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),RO-has_manifestation
503729704,7/17/2014 00:26:48,,1324563164,7/17/2014 00:26:22,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,DYSTONIA causes DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),127,18,,134,68,causes,0.936329177569044,906024-FS1-4,"A case of Leigh's DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) is reported with such noteworthy features as early onset, DYSTONIA paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",DYSTONIA,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),RO-has_manifestation
503729704,7/17/2014 01:37:35,,1324630355,7/17/2014 01:37:08,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,no_relation,127,18,,134,68,causes,0.936329177569044,906024-FS1-4,"A case of Leigh's DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) is reported with such noteworthy features as early onset, DYSTONIA paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",DYSTONIA,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),RO-has_manifestation
503729704,7/17/2014 03:10:21,,1324722871,7/17/2014 03:09:53,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) causes DYSTONIA,127,18,,134,68,causes,0.936329177569044,906024-FS1-4,"A case of Leigh's DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) is reported with such noteworthy features as early onset, DYSTONIA paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",DYSTONIA,DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),RO-has_manifestation
503729705,7/16/2014 22:25:45,,1324511370,7/16/2014 22:25:20,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,85,141,,96,165,treats,0.975900072948533,902641-FS1-2,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729705,7/16/2014 23:17:25,,1324531614,7/16/2014 23:16:55,eup_slw,0.7375,20818028,GBR,A7,Birmingham,92.232.139.254,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641-FS1-2,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729705,7/16/2014 23:26:14,,1324536041,7/16/2014 23:25:58,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641-FS1-2,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729705,7/17/2014 00:32:53,,1324568259,7/17/2014 00:32:24,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641-FS1-2,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729705,7/17/2014 01:13:46,,1324606711,7/17/2014 01:13:21,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641-FS1-2,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729705,7/17/2014 03:10:21,,1324722883,7/17/2014 03:09:53,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641-FS1-2,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729705,7/17/2014 06:04:14,,1324878371,7/17/2014 06:03:41,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641-FS1-2,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
503729706,7/16/2014 22:25:45,,1324511372,7/16/2014 22:25:20,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,28,77,,42,102,causes,0.441726104299386,901958-FS1-4,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729706,7/16/2014 22:46:22,,1324519908,7/16/2014 22:46:07,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,PSAMMOMA BODIES causes DUODENAL SOMATOSTATINOMAS,28,77,,42,102,causes,0.441726104299386,901958-FS1-4,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729706,7/17/2014 00:28:40,,1324564843,7/17/2014 00:28:12,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,no_relation,28,77,,42,102,causes,0.441726104299386,901958-FS1-4,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729706,7/17/2014 03:10:44,,1324723259,7/17/2014 03:10:22,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,DUODENAL SOMATOSTATINOMAS causes PSAMMOMA BODIES,28,77,,42,102,causes,0.441726104299386,901958-FS1-4,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729706,7/17/2014 03:41:29,,1324752973,7/17/2014 03:41:06,instagc,0.7319,20183814,USA,"","",166.182.81.199,DUODENAL SOMATOSTATINOMAS causes PSAMMOMA BODIES,28,77,,42,102,causes,0.441726104299386,901958-FS1-4,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729706,7/17/2014 06:12:19,,1324885308,7/17/2014 06:12:02,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,no_relation,28,77,,42,102,causes,0.441726104299386,901958-FS1-4,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729706,7/17/2014 09:32:33,,1325086783,7/17/2014 09:32:16,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,no_relation,28,77,,42,102,causes,0.441726104299386,901958-FS1-4,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729707,7/16/2014 22:51:17,,1324521763,7/16/2014 22:50:49,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,CONDITION (BINGE) causes BINGE EATING,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/16/2014 23:25:50,,1324535871,7/16/2014 23:25:29,instagc,0.7639,13763729,USA,"","",75.182.89.225,CONDITION (BINGE) causes BINGE EATING,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/16/2014 23:25:58,,1324535932,7/16/2014 23:25:41,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,CONDITION (BINGE) causes BINGE EATING,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/17/2014 00:31:45,,1324567325,7/17/2014 00:31:10,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/17/2014 07:29:45,,1324962728,7/17/2014 07:29:16,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,CONDITION (BINGE) causes BINGE EATING,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/17/2014 10:02:37,,1325115467,7/17/2014 10:02:19,prodege,0.7163,25949006,GBR,"","",62.249.242.67,no_relation,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729707,7/17/2014 10:33:55,,1325141285,7/17/2014 10:33:30,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,CONDITION (BINGE) causes BINGE EATING,173,96,,184,113,causes,0.680413817439772,904730-FS1-4,"Primary end points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic CONDITION (BINGE) Clinical Global Impression (CGI) scores, and the number of BINGE EATING episodes per week.",BINGE EATING,CONDITION (BINGE),RO-has_definitional_manifestation
503729708,7/16/2014 23:10:23,,1324528797,7/16/2014 23:09:57,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,43,84,,64,90,causes,0.74535599249993,908185-FS1-4,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729708,7/17/2014 04:44:33,,1324810426,7/17/2014 04:44:16,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,OXYGEN causes DECOMPRESSION SICKNESS,43,84,,64,90,causes,0.74535599249993,908185-FS1-4,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729708,7/17/2014 04:58:19,,1324822679,7/17/2014 04:57:57,prodege,0.7105,27934334,GBR,"","",86.130.153.15,no_relation,43,84,,64,90,causes,0.74535599249993,908185-FS1-4,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729708,7/17/2014 06:04:14,,1324878357,7/17/2014 06:03:41,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,OXYGEN causes DECOMPRESSION SICKNESS,43,84,,64,90,causes,0.74535599249993,908185-FS1-4,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729708,7/17/2014 10:33:09,,1325140604,7/17/2014 10:32:59,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,OXYGEN causes DECOMPRESSION SICKNESS,43,84,,64,90,causes,0.74535599249993,908185-FS1-4,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729708,7/17/2014 10:37:22,,1325144098,7/17/2014 10:37:08,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,OXYGEN causes DECOMPRESSION SICKNESS,43,84,,64,90,causes,0.74535599249993,908185-FS1-4,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729708,7/17/2014 10:37:52,,1325144454,7/17/2014 10:37:26,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,OXYGEN causes DECOMPRESSION SICKNESS,43,84,,64,90,causes,0.74535599249993,908185-FS1-4,"If the oxygen is too low, the incidence of DECOMPRESSION SICKNESS increases; if the OXYGEN is too high, oxygen poisoning becomes a problem.",DECOMPRESSION SICKNESS,OXYGEN,RO-may_treat
503729709,7/16/2014 22:28:36,,1324512775,7/16/2014 22:28:23,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,STAPHYLOCOCCI causes STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,causes,0.762492851663023,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 01:32:32,,1324625141,7/17/2014 01:32:24,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,STAPHYLOCOCCI causes STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,causes,0.762492851663023,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 02:35:40,,1324688034,7/17/2014 02:35:02,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,STAPHYLOCOCCI causes STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,causes,0.762492851663023,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 03:10:44,,1324723257,7/17/2014 03:10:22,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,115,202,,127,227,causes,0.762492851663023,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 04:58:19,,1324822683,7/17/2014 04:57:57,prodege,0.7105,27934334,GBR,"","",86.130.153.15,STAPHYLOCOCCI causes STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,causes,0.762492851663023,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 07:30:03,,1324963124,7/17/2014 07:29:46,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,STAPHYLOCOCCI causes STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,causes,0.762492851663023,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729709,7/17/2014 07:55:28,,1324990762,7/17/2014 07:54:56,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,115,202,,127,227,causes,0.762492851663023,903638-FS1-4,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729710,7/16/2014 22:29:43,,1324513221,7/16/2014 22:29:07,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.970494958830946,907513-FS1-2,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
503729710,7/16/2014 23:26:51,,1324536291,7/16/2014 23:26:35,instagc,0.7639,13763729,USA,"","",75.182.89.225,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.970494958830946,907513-FS1-2,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
503729710,7/16/2014 23:43:04,,1324543121,7/16/2014 23:42:53,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,HYPERCHOLESTEROLEMIA treats LOVASTATIN,161,117,,180,127,treats,0.970494958830946,907513-FS1-2,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
503729710,7/16/2014 23:47:27,,1324544680,7/16/2014 23:46:16,clixsense,0.6403,23585686,GBR,H9,London,31.51.221.173,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.970494958830946,907513-FS1-2,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
503729710,7/16/2014 23:54:18,,1324547336,7/16/2014 23:53:47,gifthulk,0.9056,21916793,GBR,"","",87.115.178.12,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.970494958830946,907513-FS1-2,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
503729710,7/17/2014 00:09:01,,1324554505,7/17/2014 00:08:37,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,LOVASTATIN treats HYPERCHOLESTEROLEMIA,161,117,,180,127,treats,0.970494958830946,907513-FS1-2,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
503729710,7/17/2014 00:18:48,,1324558417,7/17/2014 00:18:28,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,161,117,,180,127,treats,0.970494958830946,907513-FS1-2,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, LOVASTATIN and fluvastatin in patients with HYPERCHOLESTEROLEMIA (the CURVES study.",HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
503729711,7/16/2014 22:24:36,,1324510919,7/16/2014 22:24:21,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,TENDONS is location of TENDON RUPTURE,47,11,,53,25,is location of,0.762000762001143,905252-FS1-9,Subsequent TENDON RUPTURE was minimal and even TENDONS found to be thinned out at the time of surgery remained intact.,TENDONS,TENDON RUPTURE,RO-has_finding_site
503729711,7/16/2014 22:27:58,,1324512456,7/16/2014 22:27:45,clixsense,0.8194,16827630,GBR,A7,Birmingham,86.146.169.103,TENDON RUPTURE is location of TENDONS,47,11,,53,25,is location of,0.762000762001143,905252-FS1-9,Subsequent TENDON RUPTURE was minimal and even TENDONS found to be thinned out at the time of surgery remained intact.,TENDONS,TENDON RUPTURE,RO-has_finding_site
503729711,7/16/2014 22:28:47,,1324512837,7/16/2014 22:28:28,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,TENDONS is location of TENDON RUPTURE,47,11,,53,25,is location of,0.762000762001143,905252-FS1-9,Subsequent TENDON RUPTURE was minimal and even TENDONS found to be thinned out at the time of surgery remained intact.,TENDONS,TENDON RUPTURE,RO-has_finding_site
503729711,7/16/2014 22:37:38,,1324516693,7/16/2014 22:37:25,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,TENDONS is location of TENDON RUPTURE,47,11,,53,25,is location of,0.762000762001143,905252-FS1-9,Subsequent TENDON RUPTURE was minimal and even TENDONS found to be thinned out at the time of surgery remained intact.,TENDONS,TENDON RUPTURE,RO-has_finding_site
503729711,7/16/2014 23:09:56,,1324528672,7/16/2014 23:09:25,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,47,11,,53,25,is location of,0.762000762001143,905252-FS1-9,Subsequent TENDON RUPTURE was minimal and even TENDONS found to be thinned out at the time of surgery remained intact.,TENDONS,TENDON RUPTURE,RO-has_finding_site
503729711,7/17/2014 00:27:51,,1324564108,7/17/2014 00:27:30,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,TENDONS is location of TENDON RUPTURE,47,11,,53,25,is location of,0.762000762001143,905252-FS1-9,Subsequent TENDON RUPTURE was minimal and even TENDONS found to be thinned out at the time of surgery remained intact.,TENDONS,TENDON RUPTURE,RO-has_finding_site
503729711,7/17/2014 00:49:04,,1324583417,7/17/2014 00:48:59,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,TENDON RUPTURE is location of TENDONS,47,11,,53,25,is location of,0.762000762001143,905252-FS1-9,Subsequent TENDON RUPTURE was minimal and even TENDONS found to be thinned out at the time of surgery remained intact.,TENDONS,TENDON RUPTURE,RO-has_finding_site
503729712,7/16/2014 22:33:57,,1324514805,7/16/2014 22:33:19,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,94,0,,107,24,is location of,0.314485451016576,900255-FS1-9,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729712,7/16/2014 22:36:40,,1324516171,7/16/2014 22:36:22,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,no_relation,94,0,,107,24,is location of,0.314485451016576,900255-FS1-9,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729712,7/16/2014 23:32:21,,1324538633,7/16/2014 23:31:55,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,94,0,,107,24,is location of,0.314485451016576,900255-FS1-9,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729712,7/17/2014 07:29:14,,1324962094,7/17/2014 07:28:51,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,94,0,,107,24,is location of,0.314485451016576,900255-FS1-9,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729712,7/17/2014 09:30:52,,1325084806,7/17/2014 09:30:25,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,no_relation,94,0,,107,24,is location of,0.314485451016576,900255-FS1-9,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729712,7/17/2014 09:31:31,,1325085596,7/17/2014 09:30:56,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,ENDEMIC GOITER is location of SELENIUM (SE) DEFICIENCY,94,0,,107,24,is location of,0.314485451016576,900255-FS1-9,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729712,7/17/2014 10:35:25,,1325142658,7/17/2014 10:35:06,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,SELENIUM (SE) DEFICIENCY is location of ENDEMIC GOITER,94,0,,107,24,is location of,0.314485451016576,900255-FS1-9,SELENIUM (SE) DEFICIENCY is said to contribute to the atrophy of the thyroid gland in certain ENDEMIC GOITER areas in Africa.,ENDEMIC GOITER,SELENIUM (SE) DEFICIENCY,RO-cause_of
503729713,7/16/2014 22:31:26,,1324513901,7/16/2014 22:30:48,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,no_relation,66,88,,86,119,causes,0.348155311911396,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 00:27:30,,1324563800,7/17/2014 00:27:08,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,no_relation,66,88,,86,119,causes,0.348155311911396,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 02:34:58,,1324687341,7/17/2014 02:34:21,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,66,88,,86,119,causes,0.348155311911396,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 06:01:52,,1324876482,7/17/2014 06:01:26,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,MONOCLONAL GAMMOPATHY causes WALDENSTROM'S MACROGLOBULINEMIA,66,88,,86,119,causes,0.348155311911396,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 07:25:03,,1324957272,7/17/2014 07:24:17,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,MONOCLONAL GAMMOPATHY causes WALDENSTROM'S MACROGLOBULINEMIA,66,88,,86,119,causes,0.348155311911396,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 07:45:29,,1324980189,7/17/2014 07:44:43,vivatic,0.5413,25451531,GBR,"","",83.67.28.193,no_relation,66,88,,86,119,causes,0.348155311911396,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 07:58:20,,1324993575,7/17/2014 07:57:35,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,66,88,,86,119,causes,0.348155311911396,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729714,7/16/2014 22:36:40,,1324516159,7/16/2014 22:36:22,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.993127066322841,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 03:08:02,,1324720708,7/17/2014 03:07:38,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.993127066322841,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 06:38:15,,1324908080,7/17/2014 06:37:39,instagc,0.5978,18634892,USA,"","",68.102.93.185,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.993127066322841,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 10:33:35,,1325140965,7/17/2014 10:33:27,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.993127066322841,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 10:35:05,,1325142284,7/17/2014 10:34:52,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.993127066322841,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 10:37:52,,1325144468,7/17/2014 10:37:26,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.993127066322841,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729714,7/17/2014 10:59:57,,1325161208,7/17/2014 10:59:28,elite,0.7556,28397222,GBR,Y4,Usk,31.50.223.75,ATROPINE treats BRADYCARDIA,81,116,,91,124,treats,0.993127066322841,908049-FS1-2,Bilateral vagotomy also inhibited both effects whereas atropine only reduced the BRADYCARDIA but the combination of ATROPINE and tertatolol suppressed the bradycardia.,BRADYCARDIA,ATROPINE,RO-may_treat
503729715,7/16/2014 22:45:48,,1324519638,7/16/2014 22:45:30,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,HISTOPLASMOSIS diagnosed by HISTOPLASMIN,39,66,,52,78,diagnosed by,0.942809041582064,906592-FS1-13,The second was composed of 15 cases of HISTOPLASMOSIS with strong HISTOPLASMIN skin tests.,HISTOPLASMOSIS,HISTOPLASMIN,RO-may_diagnose
503729715,7/16/2014 22:50:13,,1324521291,7/16/2014 22:49:49,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,HISTOPLASMOSIS diagnosed by HISTOPLASMIN,39,66,,52,78,diagnosed by,0.942809041582064,906592-FS1-13,The second was composed of 15 cases of HISTOPLASMOSIS with strong HISTOPLASMIN skin tests.,HISTOPLASMOSIS,HISTOPLASMIN,RO-may_diagnose
503729715,7/17/2014 02:37:32,,1324690058,7/17/2014 02:36:49,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,39,66,,52,78,diagnosed by,0.942809041582064,906592-FS1-13,The second was composed of 15 cases of HISTOPLASMOSIS with strong HISTOPLASMIN skin tests.,HISTOPLASMOSIS,HISTOPLASMIN,RO-may_diagnose
503729715,7/17/2014 03:42:18,,1324753802,7/17/2014 03:41:45,instagc,0.7319,20183814,USA,"","",166.182.81.199,HISTOPLASMOSIS diagnosed by HISTOPLASMIN,39,66,,52,78,diagnosed by,0.942809041582064,906592-FS1-13,The second was composed of 15 cases of HISTOPLASMOSIS with strong HISTOPLASMIN skin tests.,HISTOPLASMOSIS,HISTOPLASMIN,RO-may_diagnose
503729715,7/17/2014 04:44:58,,1324810871,7/17/2014 04:44:34,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,HISTOPLASMOSIS diagnosed by HISTOPLASMIN,39,66,,52,78,diagnosed by,0.942809041582064,906592-FS1-13,The second was composed of 15 cases of HISTOPLASMOSIS with strong HISTOPLASMIN skin tests.,HISTOPLASMOSIS,HISTOPLASMIN,RO-may_diagnose
503729715,7/17/2014 07:05:36,,1324935096,7/17/2014 07:05:27,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,HISTOPLASMOSIS diagnosed by HISTOPLASMIN,39,66,,52,78,diagnosed by,0.942809041582064,906592-FS1-13,The second was composed of 15 cases of HISTOPLASMOSIS with strong HISTOPLASMIN skin tests.,HISTOPLASMOSIS,HISTOPLASMIN,RO-may_diagnose
503729715,7/17/2014 08:32:26,,1325032577,7/17/2014 08:31:43,prodege,0.5179,12641652,GBR,S9,Newry,31.48.14.129,no_relation,39,66,,52,78,diagnosed by,0.942809041582064,906592-FS1-13,The second was composed of 15 cases of HISTOPLASMOSIS with strong HISTOPLASMIN skin tests.,HISTOPLASMOSIS,HISTOPLASMIN,RO-may_diagnose
503729716,7/16/2014 22:24:28,,1324510858,7/16/2014 22:24:02,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 01:32:22,,1324624970,7/17/2014 01:32:17,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 06:01:52,,1324876483,7/17/2014 06:01:26,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,ASCITES treats FUROSEMIDE,100,69,,106,79,treats,1,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 07:44:39,,1324979192,7/17/2014 07:44:29,instagc,0.698,18960682,GBR,"","",86.29.147.112,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 09:31:56,,1325086063,7/17/2014 09:31:33,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 10:01:01,,1325114016,7/17/2014 10:00:34,prodege,0.7163,25949006,GBR,"","",62.249.242.67,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
503729716,7/17/2014 10:34:09,,1325141472,7/17/2014 10:33:55,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,FUROSEMIDE treats ASCITES,100,69,,106,79,treats,1,907842-FS1-2,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and FUROSEMIDE in the treatment of ASCITES: cooperative study.",ASCITES,FUROSEMIDE,RO-may_treat
